Sensata Technologies Holding (ST) 10-Q 1 Nov 22 2022 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2022	Oct. 14, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	001-34652
Entity Registrant Name	SENSATA TECHNOLOGIES HOLDING PLC
Entity Incorporation, State or Country Code	X0
Entity Tax Identification Number	98-1386780
Entity Address, Address Line One	529 Pleasant Street
Entity Address, City or Town	Attleboro
Entity Address, State or Province	MA
Entity Address, Postal Zip Code	02703
Entity Address, Country	US
City Area Code	+1 (508)
Local Phone Number	236 3800
Title of 12(b) Security	Ordinary Shares - nominal value €0.01 per share
Trading Symbol	ST
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)		152,961,552
Entity Central Index Key	0001477294
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 1,103,916	$ 1,708,955
Accounts receivable, net of allowances of $33,828 and $17,003 as of September 30, 2022 and December 31, 2021, respectively	722,934	653,438
Inventories	675,862	588,231
Prepaid expenses and other current assets	197,487	126,370
Total current assets	2,700,199	3,076,994
Property, plant and equipment, net	831,587	820,933
Goodwill	3,847,450	3,502,063
Other intangible assets, net of accumulated amortization of $2,361,199 and $2,277,393 as of September 30, 2022 and December 31, 2021, respectively	1,103,256	946,731
Deferred income tax assets	100,014	105,028
Other assets	130,110	162,017
Total assets	8,712,616	8,613,766
Current liabilities:
Current portion of long-term debt, finance lease and other financing obligations	6,536	6,833
Accounts payable	501,301	459,093
Income taxes payable	42,732	26,517
Accrued expenses and other current liabilities	355,405	343,816
Total current liabilities	905,974	836,259
Deferred income tax liabilities	392,222	339,273
Pension and other post-retirement benefit obligations	35,445	38,758
Finance lease and other financing obligations, less current portion	25,180	26,564
Long-term debt, net	4,208,670	4,214,946
Other long-term liabilities	75,807	63,232
Total liabilities	5,643,298	5,519,032
Commitments and contingencies (Note 12)
Shareholders’ equity:
Ordinary shares, €0.01 nominal value per share, 177,069 shares authorized, and 174,983 and 174,287 shares issued as of September 30, 2022 and December 31, 2021, respectively	2,240	2,232
Treasury shares, at cost, 21,615 and 16,438 shares as of September 30, 2022 and December 31, 2021, respectively	(1,077,041)	(832,439)
Additional paid-in capital	1,852,249	1,812,244
Retained earnings	2,287,683	2,132,257
Accumulated other comprehensive income/(loss)	4,187	(19,560)
Total shareholders' equity	3,069,318	3,094,734
Total liabilities and shareholders' equity	$ 8,712,616	$ 8,613,766

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) $ in Thousands	Sep. 30, 2022 USD ($) shares	Sep. 30, 2022 € / shares	Dec. 31, 2021 USD ($) shares	Dec. 31, 2021 € / shares
Statement of Financial Position [Abstract]
Accounts receivable, allowances | $	$ 33,828		$ 17,003
Accumulated amortization | $	$ 2,361,199		$ 2,277,393
Ordinary shares, nominal value per share (in euros per share) | € / shares		€ 0.01		€ 0.01
Ordinary shares authorized (in shares)	177,069,000		177,069,000
Ordinary shares issued (in shares)	174,983,000		174,287,000
Treasury shares (in shares)	21,615,000		16,438,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Statement [Abstract]
Net revenue	$ 1,018,268	$ 951,021	$ 3,014,586	$ 2,886,209
Operating costs and expenses:
Cost of revenue	694,535	628,922	2,038,218	1,922,556
Research and development	47,947	40,060	141,898	118,929
Selling, general and administrative	90,013	85,784	283,022	249,728
Amortization of intangible assets	40,313	34,571	114,485	101,492
Restructuring and other charges, net	(107,441)	345	(80,811)	9,956
Total operating costs and expenses	765,367	789,682	2,496,812	2,402,661
Operating income	252,901	161,339	517,774	483,548
Interest expense, net	(44,856)	(45,137)	(135,143)	(134,393)
Other, net	(21,371)	(9,403)	(111,067)	(47,788)
Income before taxes	186,674	106,799	271,564	301,367
Provision for income taxes	46,421	21,840	74,029	49,759
Net income	$ 140,253	$ 84,959	$ 197,535	$ 251,608
Basic net income per share (in dollars per share)	$ 0.91	$ 0.54	$ 1.27	$ 1.59
Diluted net income per share (in dollars per share)	$ 0.91	$ 0.53	$ 1.26	$ 1.58

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Statement of Comprehensive Income [Abstract]
Net income	$ 140,253	$ 84,959	$ 197,535	$ 251,608
Other comprehensive income:
Cash flow hedges	10,329	2,975	22,362	18,651
Defined benefit and retiree healthcare plans	577	594	1,385	3,978
Other comprehensive income	10,906	3,569	23,747	22,629
Comprehensive income	$ 151,159	$ 88,528	$ 221,282	$ 274,237

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net income	$ 197,535	$ 251,608
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	94,562	94,361
Amortization of debt issuance costs	5,256	5,142
Gain on sale of business	(135,112)	0
Share-based compensation	24,180	18,871
Loss on debt financing	5,468	30,066
Amortization of intangible assets	114,485	101,492
Deferred income taxes	3,313	(2,070)
Acquisition-related compensation payments	(23,500)	(7,000)
Mark-to-market loss on equity investments, net	75,135	0
Unrealized loss on derivative instruments and other	40,702	17,359
Changes in operating assets and liabilities, net of the effects of acquisitions:
Accounts receivable, net	(88,617)	(66,340)
Inventories	(77,059)	(93,651)
Prepaid expenses and other current assets	(24,145)	(14,890)
Accounts payable and accrued expenses	10,928	44,879
Income taxes payable	16,205	13,615
Other	(3,603)	(216)
Net cash provided by operating activities	235,733	393,226
Cash flows from investing activities:
Acquisitions, net of cash received	(632,683)	(414,959)
Additions to property, plant and equipment and capitalized software	(110,424)	(100,410)
Investment in debt and equity securities	(7,773)	(4,655)
Proceeds from the sale of business, net of cash sold	198,841	0
Other	152	3,919
Net cash used in investing activities	(551,887)	(516,105)
Cash flows from financing activities:
Proceeds from exercise of stock options and issuance of ordinary shares	16,460	20,016
Payment of employee restricted stock tax withholdings	(7,834)	(8,987)
Proceeds from borrowings on debt	500,000	1,001,875
Payments on debt	(507,968)	(760,768)
Dividends paid	(34,271)	0
Payments to repurchase ordinary shares	(241,903)	0
Payments of debt financing costs	(13,369)	(33,093)
Net cash (used in)/provided by financing activities	(288,885)	219,043
Net change in cash and cash equivalents	(605,039)	96,164
Cash and cash equivalents, beginning of year	1,708,955	1,861,980
Cash and cash equivalents, end of period	$ 1,103,916	$ 1,958,144

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Ordinary Shares	Treasury Shares	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Income/(Loss)
Beginning balance (in shares) at Dec. 31, 2020		173,266
Beginning balance (in shares) at Dec. 31, 2020			(15,631)
Beginning balance at Dec. 31, 2020	$ 2,705,486	$ 2,220	$ (784,596)	$ 1,759,668	$ 1,777,729	$ (49,535)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Surrender of shares for tax withholding (in shares)			(154)
Surrender of shares for tax withholding	(8,987)		$ (8,987)
Stock options exercised (in shares)		501
Stock options exercised	20,016	$ 6		20,010
Vesting of restricted securities (in shares)		466
Vesting of restricted securities	0	$ 6			(6)
Retirement of ordinary shares (in shares)		154	154
Retirement of ordinary shares	0	$ (2)	$ 8,987		(8,985)
Share-based compensation	18,871			18,871
Net income	251,608				251,608
Other comprehensive income	22,629					22,629
Ending balance (in shares) at Sep. 30, 2021		174,079
Ending balance (in shares) at Sep. 30, 2021			(15,631)
Ending balance at Sep. 30, 2021	3,009,623	$ 2,230	$ (784,596)	1,798,549	2,020,346	(26,906)
Beginning balance (in shares) at Jun. 30, 2021		174,005
Beginning balance (in shares) at Jun. 30, 2021			(15,631)
Beginning balance at Jun. 30, 2021	2,913,448	$ 2,229	$ (784,596)	1,789,863	1,936,427	(30,475)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Surrender of shares for tax withholding (in shares)			(18)
Surrender of shares for tax withholding	(1,039)		$ (1,039)
Stock options exercised (in shares)		34
Stock options exercised	1,290	$ 0		1,290
Vesting of restricted securities (in shares)		58
Vesting of restricted securities	0	$ 1			(1)
Retirement of ordinary shares (in shares)		18	18
Retirement of ordinary shares	0		$ 1,039		(1,039)
Share-based compensation	7,396			7,396
Net income	84,959				84,959
Other comprehensive income	3,569					3,569
Ending balance (in shares) at Sep. 30, 2021		174,079
Ending balance (in shares) at Sep. 30, 2021			(15,631)
Ending balance at Sep. 30, 2021	$ 3,009,623	$ 2,230	$ (784,596)	1,798,549	2,020,346	(26,906)
Beginning balance (in shares) at Dec. 31, 2021		174,287
Beginning balance (in shares) at Dec. 31, 2021	(16,438)		(16,438)
Beginning balance at Dec. 31, 2021	$ 3,094,734	$ 2,232	$ (832,439)	1,812,244	2,132,257	(19,560)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Surrender of shares for tax withholding (in shares)			(157)
Surrender of shares for tax withholding	(7,834)		$ (7,834)
Stock options exercised (in shares)		374
Stock options exercised	15,829	$ 4		15,825
Vesting of restricted securities (in shares)		479
Vesting of restricted securities	0	$ 6			(6)
Cash dividends paid	(34,271)				(34,271)
Repurchase of ordinary shares (in shares)			(5,177)
Repurchase of ordinary shares	(244,602)		$ (244,602)
Retirement of ordinary shares (in shares)		157	157
Retirement of ordinary shares	0	$ (2)	$ 7,834		(7,832)
Share-based compensation	24,180			24,180
Net income	197,535				197,535
Other comprehensive income	$ 23,747					23,747
Ending balance (in shares) at Sep. 30, 2022		174,983
Ending balance (in shares) at Sep. 30, 2022	(21,615)		(21,615)
Ending balance at Sep. 30, 2022	$ 3,069,318	$ 2,240	$ (1,077,041)	1,852,249	2,287,683	4,187
Beginning balance (in shares) at Jun. 30, 2022		174,924
Beginning balance (in shares) at Jun. 30, 2022			(19,269)
Beginning balance at Jun. 30, 2022	3,023,584	$ 2,239	$ (978,595)	1,841,925	2,164,734	(6,719)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Surrender of shares for tax withholding (in shares)			(6)
Surrender of shares for tax withholding	(257)		$ (257)
Stock options exercised (in shares)		45
Stock options exercised	1,883			1,883
Vesting of restricted securities (in shares)		20
Vesting of restricted securities	0	$ 1			(1)
Cash dividends paid	(17,046)				(17,046)
Repurchase of ordinary shares (in shares)			(2,346)
Repurchase of ordinary shares	(98,446)		$ (98,446)
Retirement of ordinary shares (in shares)		6	6
Retirement of ordinary shares	0		$ 257		(257)
Share-based compensation	8,441			8,441
Net income	140,253				140,253
Other comprehensive income	$ 10,906					10,906
Ending balance (in shares) at Sep. 30, 2022		174,983
Ending balance (in shares) at Sep. 30, 2022	(21,615)		(21,615)
Ending balance at Sep. 30, 2022	$ 3,069,318	$ 2,240	$ (1,077,041)	$ 1,852,249	$ 2,287,683	$ 4,187

Basis of Presentation

Basis of Presentation	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements reflect the financial position, results of operations, comprehensive income, cash flows, and changes in shareholders' equity of Sensata Technologies Holding plc, a public limited company incorporated under the laws of England and Wales, and its consolidated subsidiaries, collectively referred to as the "Company," "Sensata," "we," "our," or "us." The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States ("U.S.") generally accepted accounting principles ("GAAP") for interim financial information and the instructions to Form 10-Q. Accordingly, these interim financial statements do not include all of the information and note disclosures required by U.S. GAAP for complete financial statements. The accompanying financial information reflects all normal recurring adjustments that are, in the opinion of management, necessary for a fair presentation of the interim period results. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2021 filed with the U.S. Securities and Exchange Commission (the "SEC") on February 10, 2022 (the "2021 Annual Report"). All U.S. dollar ("USD") and share amounts presented, except per share amounts, are stated in thousands, unless otherwise indicated. Certain reclassifications have been made to prior periods to conform to current period presentation.

New Accounting Standards

New Accounting Standards	9 Months Ended
	Sep. 30, 2022
Accounting Standards Update and Change in Accounting Principle [Abstract]
New Accounting Standards	New Accounting StandardsThere are no recently issued accounting standards that have been adopted in the current period or will be adopted in future periods that have had or are expected to have a material impact on our consolidated financial position or results of operations.

Revenue Recognition

Revenue Recognition	9 Months Ended
	Sep. 30, 2022
Revenue Recognition and Deferred Revenue [Abstract]
Revenue Recognition	Revenue Recognition The following table presents net revenue disaggregated by segment and end market for the three and nine months ended September 30, 2022 and 2021: For the three months ended September 30, 2022 For the three months ended September 30, 2021 Performance Sensing Sensing Solutions Total Performance Sensing Sensing Solutions Total Automotive $ 525,271 $ 8,616 $ 533,887 $ 488,041 $ 9,451 $ 497,492 HVOR (1) 229,256 — 229,256 218,425 — 218,425 Industrial — 147,191 147,191 — 106,809 106,809 Appliance and HVAC (2) — 51,927 51,927 — 62,793 62,793 Aerospace — 37,789 37,789 — 34,377 34,377 Other — 18,218 18,218 — 31,125 31,125 Total $ 754,527 $ 263,741 $ 1,018,268 $ 706,466 $ 244,555 $ 951,021 ___________________________________ (1) Heavy vehicle and off-road (2) Heating, ventilation and air conditioning For the nine months ended September 30, 2022 For the nine months ended September 30, 2021 Performance Sensing Sensing Solutions Total Performance Sensing Sensing Solutions Total Automotive $ 1,533,865 $ 27,833 $ 1,561,698 $ 1,543,121 $ 33,003 $ 1,576,124 HVOR 685,241 — 685,241 619,709 — 619,709 Industrial — 385,470 385,470 — 302,758 302,758 Appliance and HVAC — 168,427 168,427 — 185,896 185,896 Aerospace — 109,617 109,617 — 99,847 99,847 Other — 104,133 104,133 — 101,875 101,875 Total $ 2,219,106 $ 795,480 $ 3,014,586 $ 2,162,830 $ 723,379 $ 2,886,209

Share-Based Payment Plans

Share-Based Payment Plans	9 Months Ended
	Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]
Share-Based Payment Plans	Share-Based Payment Plans The following table presents the components of non-cash compensation expense related to our equity awards for the three and nine months ended September 30, 2022 and 2021: For the three months ended For the nine months ended September 30, 2022 September 30, 2021 September 30, 2022 September 30, 2021 Stock options $ 158 $ 307 $ 467 $ 1,072 Restricted securities 8,283 7,089 23,713 17,799 Share-based compensation expense $ 8,441 $ 7,396 $ 24,180 $ 18,871 Equity Awards We granted the following restricted stock units ("RSUs" and each, an "RSU") and performance-based restricted stock units ("PRSUs" and each, a "PRSU") under the Sensata Technologies Holding plc 2021 Equity Incentive Plan during the nine months ended September 30, 2022: Awards Granted To: Type of Award Number of Units Granted (in thousands) Percentage of PRSUs Awarded that May Vest Weighted Average Grant Date Fair Value Directors RSU (1) 29 N/A $ 46.30 Various executives and employees RSU (2) 583 N/A $ 49.97 Various executives and employees PRSU (3) 420 0.0% - 200.0% $ 49.45 ____________________________________ (1) These RSUs cliff vest one year from the grant date (May 2023). (2) These RSUs vest ratably over three years, one-third per year beginning on the first anniversary of the grant date. These RSUs will fully vest on various dates between January 2025 and September 2025. (3) These PRSUs vest on various dates between April 2025 and September 2025. The number of units that ultimately vest is dependent on the achievement of certain performance criteria.

Restructuring and Other Charges

Restructuring and Other Charges, Net	9 Months Ended
	Sep. 30, 2022
Restructuring and Related Activities [Abstract]
Restructuring and Other Charges, Net	Restructuring and Other Charges, Net The following table presents the components of restructuring and other charges, net for the three and nine months ended September 30, 2022 and 2021: For the three months ended For the nine months ended September 30, 2022 September 30, 2021 September 30, 2022 September 30, 2021 Q2 2020 Global Restructure Program charges $ — $ 3,098 $ — $ 8,752 Other restructuring and other charges, net Severance costs, net 6,249 133 6,836 726 Facility and other exit costs 2,181 541 4,470 1,832 Gain on sale of Qinex Business (135,112) — (135,112) — Acquisition-related compensation arrangements 7,359 — 38,448 — Other (1) 11,882 (3,427) 4,547 (1,354) Restructuring and other charges, net $ (107,441) $ 345 $ (80,811) $ 9,956 ___________________________________ (1) Primarily includes, in the three and nine months ended September 30, 2022, transaction-related charges to sell the Qinex Business, partially offset in the nine months ended September 30, 2022 by gains related to changes in the fair value of acquisition-related contingent consideration amounts. Refer to Note 16: Acquisitions and Divestitures for additional information. The following table presents a rollforward of the severance portion of our restructuring obligations for the nine months ended September 30, 2022. Q2 2020 Global Restructure Program Other Total Balance as of December 31, 2021 $ 3,853 $ 3,380 $ 7,233 Charges, net of reversals — 6,836 6,836 Payments (3,129) (2,323) (5,452) Foreign currency remeasurement (90) (281) (371) Balance as of September 30, 2022 $ 634 $ 7,612 $ 8,246 The severance liability as of September 30, 2022 was entirely recorded in accrued expenses and other current liabilities on our condensed consolidated balance sheet.

Other, Net

Other, Net	9 Months Ended
	Sep. 30, 2022
Other Income and Expenses [Abstract]
Other, Net	Other, Net The following table presents the components of other, net for the three and nine months ended September 30, 2022 and 2021: For the three months ended For the nine months ended September 30, 2022 September 30, 2021 September 30, 2022 September 30, 2021 Currency remeasurement (loss)/gain on net monetary assets $ (12,583) $ (324) $ (26,740) $ 187 Gain/(loss) on foreign currency forward contracts 6,178 (2,414) 8,100 (4,791) Loss on commodity forward contracts (5,773) (6,495) (14,603) (6,462) Loss on debt financing (5,468) — (5,468) (30,066) Mark-to-market loss on investments, net (4,035) — (75,135) — Net periodic benefit cost, excluding service cost (868) (1,053) (2,262) (5,731) Other 1,178 883 5,041 (925) Other, net $ (21,371) $ (9,403) $ (111,067) $ (47,788)

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The following table presents the provision for income taxes for the three and nine months ended September 30, 2022 and 2021: For the three months ended For the nine months ended September 30, 2022 September 30, 2021 September 30, 2022 September 30, 2021 Provision for income taxes $ 46,421 $ 21,840 $ 74,029 $ 49,759 The provision for income taxes consists of (1) current tax expense, which relates primarily to our profitable operations in tax jurisdictions with limited or no net operating loss carryforwards and withholding taxes related to management fees, royalties, and the repatriation of foreign earnings; and (2) deferred tax expense (or benefit), which represents adjustments in book-to-tax basis differences primarily related to (a) book versus tax basis in intangible assets, (b) changes in net operating loss carryforwards, and (c) changes in withholding taxes on unremitted earnings. Other items impacting deferred tax expense include changes in tax rates and changes in our assessment of the realizability of our deferred tax assets.

Net Income per Share

Net Income per Share	9 Months Ended
	Sep. 30, 2022
Earnings Per Share [Abstract]
Net Income per Share	Net Income per Share Basic and diluted net income per share are calculated by dividing net income by the number of basic and diluted weighted-average ordinary shares outstanding during the period. For the three and nine months ended September 30, 2022 and 2021 the weighted-average ordinary shares outstanding used to calculate basic and diluted net income per share were as follows: For the three months ended For the nine months ended September 30, 2022 September 30, 2021 September 30, 2022 September 30, 2021 Basic weighted-average ordinary shares outstanding 154,474 158,394 156,124 158,122 Dilutive effect of stock options 107 603 256 660 Dilutive effect of unvested restricted securities 362 482 475 569 Diluted weighted-average ordinary shares outstanding 154,943 159,479 156,855 159,351 Certain potential ordinary shares were excluded from our calculation of diluted weighted-average ordinary shares outstanding because either they would have had an anti-dilutive effect on net income per share or they related to equity awards that were contingently issuable for which the contingency had not been satisfied. These potential ordinary shares were as follows: For the three months ended For the nine months ended September 30, 2022 September 30, 2021 September 30, 2022 September 30, 2021 Anti-dilutive shares excluded 1,917 9 1,116 8 Contingently issuable shares excluded 1,513 1,072 1,299 1,037

Inventories

Inventories	9 Months Ended
	Sep. 30, 2022
Inventory Disclosure [Abstract]
Inventories	Inventories The following table presents the components of inventories as of September 30, 2022 and December 31, 2021: September 30, December 31, Finished goods $ 223,607 $ 201,424 Work-in-process 111,823 101,558 Raw materials 340,432 285,249 Inventories $ 675,862 $ 588,231

Pension and Other Post-Retireme

Pension and Other Post-Retirement Benefits	9 Months Ended
	Sep. 30, 2022
Retirement Benefits [Abstract]
Pension and Other Post-Retirement Benefits	Pension and Other Post-Retirement Benefits The following table presents the components of net periodic benefit cost/(credit) associated with our defined benefit and retiree healthcare plans for the three months ended September 30, 2022 and 2021: U.S. Plans Non-U.S. Plans Defined Benefit Retiree Healthcare Defined Benefit Total 2022 2021 2022 2021 2022 2021 2022 2021 Service cost $ — $ — $ 2 $ 2 $ 958 $ 725 $ 960 $ 727 Interest cost 113 167 22 21 417 405 552 593 Expected return on plan assets (195) (226) — — (214) (177) (409) (403) Amortization of net loss/(gain) 226 243 (43) — 327 461 510 704 Amortization of prior service (credit)/cost — — (100) (159) 2 3 (98) (156) Loss on settlement 313 315 — — — — 313 315 Net periodic benefit cost/(credit) $ 457 $ 499 $ (119) $ (136) $ 1,490 $ 1,417 $ 1,828 $ 1,780 The following table presents the components of net periodic benefit cost/(credit) associated with our defined benefit and retiree healthcare plans for the nine months ended September 30, 2022 and 2021: U.S. Plans Non-U.S. Plans Defined Benefit Retiree Healthcare Defined Benefit Total 2022 2021 2022 2021 2022 2021 2022 2021 Service cost $ — $ — $ 6 $ 6 $ 2,896 $ 3,028 $ 2,902 $ 3,034 Interest cost 339 407 86 63 1,267 1,210 1,692 1,680 Expected return on plan assets (585) (678) — — (700) (534) (1,285) (1,212) Amortization of net loss/(gain) 593 1,045 (86) — 935 1,382 1,442 2,427 Amortization of prior service (credit)/cost — — (300) (477) 7 19 (293) (458) Loss on settlement 706 3,294 — — — — 706 3,294 Net periodic benefit cost/(credit) $ 1,053 $ 4,068 $ (294) $ (408) $ 4,405 $ 5,105 $ 5,164 $ 8,765 Components of net periodic benefit cost/(credit) other than service cost are presented in other, net in the condensed consolidated statements of operations. Refer to Note 6: Other, Net .

Debt

Debt	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Debt	Debt The following table presents the components of long-term debt, finance lease and other financing obligations as of September 30, 2022 and December 31, 2021: Maturity Date September 30, December 31, Term Loan September 20, 2026 $ 447,992 $ 451,465 4.875% Senior Notes October 15, 2023 — 500,000 5.625% Senior Notes November 1, 2024 400,000 400,000 5.0% Senior Notes October 1, 2025 700,000 700,000 4.375% Senior Notes February 15, 2030 450,000 450,000 3.75% Senior Notes February 15, 2031 750,000 750,000 4.0% Senior Notes April 15, 2029 1,000,000 1,000,000 5.875% Senior Notes September 1, 2030 500,000 — Less: debt discount, net of premium (3,740) (5,207) Less: deferred financing costs (30,952) (26,682) Less: current portion (4,630) (4,630) Long-term debt, net $ 4,208,670 $ 4,214,946 Finance lease and other financing obligations $ 27,086 $ 28,767 Less: current portion (1,906) (2,203) Finance lease and other financing obligations, less current portion $ 25,180 $ 26,564 Our debt consists of secured credit facilities and various tranches of senior unsecured notes. Refer to Note 14: Debt of our 2021 Annual Report for additional information related to our existing indebtedness. Secured Credit Facilities On June 23, 2022, certain of our indirect, wholly-owned subsidiaries, including Sensata Technologies, Inc. ("STI"), Sensata Technologies Intermediate Holding B.V. ("STIHBV"), and Sensata Technologies B.V. (“STBV”), entered into an amendment (the “Eleventh Amendment”) to (i) the credit agreement, dated as of May 12, 2011 (as amended, supplemented, waived, or otherwise modified, the “Credit Agreement”), and (ii) the Foreign Guaranty, dated as of May 12, 2011. Among other changes to the Credit Agreement, the Eleventh Amendment (i) increased the aggregate principal amount of the revolving credit facility under the Credit Agreement (the "Revolving Credit Facility") to $750.0 million; (ii) extended the maturity date of the Revolving Credit Facility to June 23, 2027 (which could be accelerated to June 22, 2026 if, prior to June 22, 2026, the term loan under the Credit Agreement (the "Term Loan") is not refinanced with a maturity date that is on or after June 23, 2027); (iii) released the Foreign Guarantors (as defined in the Credit Agreement), excluding STBV, from their obligations to guarantee the obligations of STI and the other Loan Parties (as defined in the Credit Agreement) relating to the Revolving Credit Facility and certain related obligations, subject to an obligation to reinstate such guaranties under certain conditions; (iv) replaced the LIBOR-based interest rates referenced by the Credit Agreement regarding revolving credit loans to (a) for revolving credit loans denominated in U.S. dollars, an interest rate based on the secured overnight financing rate ("SOFR") published by the Federal Reserve Bank of New York and (b) for revolving credit loans denominated in pounds sterling, an interest rate based on the Sterling Overnight Index Average ("SONIA"); and (v) certain of the operational and restrictive covenants and other terms and conditions of the Credit Agreement were modified to provide STI and its affiliates increased flexibility and permissions thereunder. As of September 30, 2022, we had $746.1 million available under the Revolving Credit Facility, net of $3.9 million of obligations in respect of outstanding letters of credit issued thereunder. Outstanding letters of credit are issued primarily for the benefit of certain operating activities. As of September 30, 2022, no amounts had been drawn against these outstanding letters of credit. 5.875% Senior Notes On August 29, 2022, STBV completed the issuance and sale of $500.0 million aggregate principal amount of 5.875% senior notes due 2030 (the "5.875% Senior Notes"). The 5.875% Senior Notes were issued under an indenture dated as of August 29, 2022 among STBV, as issuer, The Bank of New York Mellon, as trustee, and our guarantor subsidiaries named therein (the "5.875% Senior Notes Indenture"). The 5.875% Senior Notes Indenture contains covenants that limit the ability of STBV and its subsidiaries to, among other things: incur liens; engage in sale and leaseback transactions; with respect to any subsidiary of STBV, incur indebtedness without such subsidiary’s guaranteeing the 5.875% Senior Notes; or consolidate, merge with, or sell, assign, convey, transfer, lease, or otherwise dispose of all or substantially all of their properties or assets to, another person. These covenants are subject to important exceptions and qualifications set forth in the 5.875% Senior Notes Indenture. The 5.875% Senior Notes bear interest at 5.875% per year and mature on September 1, 2030. Interest is payable semi-annually on September 1 and March 1 of each year, commencing on March 1, 2023. The 5.875% Senior Notes are guaranteed by each of STBV's wholly-owned subsidiaries that is a borrower or guarantor under the senior secured credit facilities (the "Senior Secured Credit Facilities") of STI and an issuer or a guarantor under our existing senior notes as follows: STBV's 5.625% Senior Notes due 2024, 5.0% Senior Notes due 2025, and 4.0% Senior Notes due 2029; and STI's 4.375% Senior Notes due 2030 and 3.75% Senior Notes due 2031. At any time, and from time to time, prior to September 1, 2025, STBV may redeem the 5.875% Senior Notes, in whole or in part, at a redemption price equal to 100% of the principal amount of the 5.875% Senior Notes being redeemed, plus a “make whole” premium, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. At any time on or after September 1, 2025, STBV may redeem the 5.875% Senior Notes, in whole or in part, at the following prices (expressed as a percentage of principal amount), plus accrued and unpaid interest, if any, up to but excluding the redemption date: Period beginning September 1, Price 2025 102.398 % 2026 101.469 % 2027 and thereafter 100.000 % In addition, at any time prior to September 1, 2025, STBV may redeem up to 40% of the principal amount of the outstanding 5.875% Senior Notes (including additional 5.875% Senior Notes, if any) with the net cash proceeds of certain equity offerings at a redemption price (expressed as a percentage of principal amount) of 105.875%, plus accrued and unpaid interest, if any, up to but excluding the redemption date, provided that at least 60% of the aggregate principal amount of the 5.875% Senior Notes (including additional 5.875% Senior Notes, if any) remains outstanding immediately after each such redemption. Upon the occurrence of certain changes in control, each holder of the 5.875% Senior Notes will have the right to require STBV to repurchase the 5.875% Senior Notes at 101% of their principal amount plus accrued and unpaid interest, if any, up to but excluding the date of repurchase. Upon changes in certain tax laws or treaties, or any change in the official application, administration, or interpretation thereof, STBV may, at its option, redeem the 5.875% Senior Notes, in whole but not in part, at a redemption price equal to 100% of the principal amount thereof, plus accrued and unpaid interest, if any, up to but excluding the redemption date, premium, if any, and all Additional Amounts (as defined in the 5.875% Senior Notes Indenture), if any, then due and which will become due on the date of redemption. 4.875% Senior Notes Redemption On August 29, 2022, we announced that we intended to redeem in full the $500.0 million aggregate principal amount outstanding on our 4.875% senior notes due 2023 (the "4.875% Senior Notes"). We redeemed the 4.875% Senior Notes on September 28, 2022 in accordance with the terms of the indenture under which the 4.875% Senior Notes were issued and the terms of the notice of redemption at a price of 101.0% of the aggregate principal amount of the outstanding 4.875% Senior Notes (which includes the applicable premium), plus accrued and unpaid interest to (but not including) the redemption date. Accounting for Debt Financing Transactions We account for our debt financing transactions as disclosed in Note 2: Significant Accounting Policies of the audited consolidated financial statements and notes thereto included in our 2021 Annual Report. In the nine months ended September 30, 2022, in connection with the entry into the Eleventh Amendment, we recognized $2.6 million of deferred financing costs, which are presented as a reduction of long-term debt on our condensed consolidated balance sheets. In the three months ended September 30, 2022, in connection with the issuance of the 5.875% Senior Notes, we capitalized $5.9 million of deferred financing costs, which are presented on the condensed consolidated balance sheets as a reduction of long-term debt. In connection with the redemption of the 4.875% Senior Notes, we recognized a loss of $5.5 million, presented in other, net, related to the redemption premium of $5.0 million and the write-off of unamortized deferred financing costs and debt discounts. In the nine months ended September 30, 2021, in connection with the redemption of $750.0 million aggregate principal amount of 6.25% senior notes due 2026 (the "6.25% Senior Notes"), we recognized a loss of $30.1 million, which included $23.4 million in premiums paid, with the remaining loss representing write-off of debt discounts and deferred financing costs. Accrued Interest Accrued interest associated with our outstanding debt is included as a component of accrued expenses and other current liabilities in the condensed consolidated balance sheets. As of September 30, 2022 and December 31, 2021, accrued interest totaled $54.9 million and $45.1 million, respectively.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies We are regularly involved in a number of claims and litigation matters that arise in the ordinary course of business. Although it is not feasible to predict the outcome of these matters, based upon our experience and current information known to us, we do not expect the outcome of these matters, either individually or in the aggregate, to have a material adverse effect on our results of operations, financial condition, and/or cash flows.

Shareholders' Equity

Shareholders' Equity	9 Months Ended
	Sep. 30, 2022
Equity [Abstract]
Shareholders' Equity	Shareholders' Equity Cash Dividends On August 24, 2022, we paid a cash dividend of $0.11 per share, or $17.0 million in aggregate, to shareholders of record as of August 10, 2022. Treasury Shares From time to time, our Board of Directors has authorized various share repurchase programs, which may be modified or terminated by the Board at any time. On January 20, 2022, we announced that our Board of Directors had authorized a new $500.0 million ordinary share repurchase program (the “January 2022 Program”), which replaced the previous $500.0 million program approved in July 2019, which had availability of $254.5 million as of December 31, 2021. As of September 30, 2022, $272.2 million remained available for repurchase under the January 2022 Program. Accumulated Other Comprehensive Income/(Loss) The following table presents the components of accumulated other comprehensive income/(loss) for the nine months ended September 30, 2022: Cash Flow Hedges Defined Benefit and Retiree Healthcare Plans Accumulated Other Comprehensive Income/(Loss) Balance as of December 31, 2021 $ 16,831 $ (36,391) $ (19,560) Other comprehensive income before reclassifications, net of tax 48,437 — 48,437 Reclassifications from accumulated other comprehensive income/(loss), net of tax (26,075) 1,385 (24,690) Other comprehensive income 22,362 1,385 23,747 Balance as of September 30, 2022 $ 39,193 $ (35,006) $ 4,187 The following table presents the amounts reclassified from accumulated other comprehensive income/(loss) for the three and nine months ended September 30, 2022 and 2021: For the three months ended September 30, For the nine months ended September 30, Affected Line in Condensed Consolidated Statements of Operations Component 2022 2021 2022 2021 Derivative instruments designated and qualifying as cash flow hedges: Foreign currency forward contracts $ (14,909) $ 1,976 $ (28,649) $ 9,816 Net revenue (1) Foreign currency forward contracts (1,260) (3,557) (6,492) (6,324) Cost of revenue (1) Total, before taxes (16,169) (1,581) (35,141) 3,492 Income before taxes Income tax effect 4,172 395 9,066 (873) Provision for income taxes Total, net of taxes $ (11,997) $ (1,186) $ (26,075) $ 2,619 Net income Defined benefit and retiree healthcare plans $ 725 $ 863 $ 1,855 $ 5,263 Other, net (2) Income tax effect (148) (269) (470) (1,285) Provision for income taxes Total, net of taxes $ 577 $ 594 $ 1,385 $ 3,978 Net income ___________________________________ (1) Refer to Note 15: Derivative Instruments and Hedging Activities for additional information on amounts to be reclassified from accumulated other comprehensive income/(loss) in future periods. (2) Refer to Note 10: Pension and Other Post-Retirement Benefits for additional information on net periodic benefit cost/(credit).

Fair Value Measures

Fair Value Measures	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value Measures	Fair Value Measures Measured on a Recurring Basis The fair values of our derivative assets and liabilities measured at fair value on a recurring basis as of September 30, 2022 and December 31, 2021 are shown in the below table. All fair value measures presented are categorized in Level 2 of the fair value hierarchy. September 30, December 31, Assets Foreign currency forward contracts $ 65,808 $ 25,112 Commodity forward contracts 303 2,979 Total $ 66,111 $ 28,091 Liabilities Foreign currency forward contracts $ 13,087 $ 3,073 Commodity forward contracts 14,297 4,492 Total $ 27,384 $ 7,565 Refer to Note 15: Derivative Instruments and Hedging Activities for additional information related to our forward contracts. Quanergy As of December 31, 2021, we held a $50.0 million investment in Quanergy Systems, Inc. ("Quanergy") Series B Preferred Stock (the "Series B Investment"). The Series B Investment did not have a readily determinable fair value and was held using the measurement alternative prescribed in Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 321, Investments - Equity Securities . Such investments are measured at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer. On June 22, 2021, Quanergy announced that it had entered into a definitive business combination agreement (the "Merger Agreement") with CITIC Capital Acquisition Corp ("CITIC") (NYSE: CCAC). On July 16, 2021, CITIC filed a Registration Statement on Form S-4 (together with subsequent amendments, the "SPAC Form S-4") with the SEC, the effectiveness of which was a condition to closing of the business combination (the "SPAC Merger"). At December 31, 2021, we assessed our investment in Quanergy based on the proposed terms of the Merger Agreement and concluded that there were no indicators of impairment. On January 6, 2022, the SPAC Form S-4 was declared effective by the SEC. An extraordinary general meeting of shareholders of CITIC was held on January 31, 2022, at which time the SPAC Merger was approved. The SPAC Merger closed on February 8, 2022. Beginning on February 9, 2022, the combined company, which retained the name "Quanergy Systems, Inc.," was listed on the New York Stock Exchange (the "NYSE") under the ticker symbol QNGY. Upon closing of the SPAC Merger, our investment in Quanergy comprised the following: • 5.0 million common shares, which represented the conversion of the $50.0 million Series B Investment (at a $10.00 per common share implied valuation); • 750 thousand common shares, purchased in exchange for a $7.5 million contribution as part of a private investment in public equity ("PIPE") subscription agreement; and • 2.5 million warrants (the "Warrants"), each of which represent the right to purchase one common share at a price of $0.01 per share, received from Quanergy as up-front consideration for a four-year technical and marketing support agreement (the "Support Agreement"). The 5.75 million common share investment in Quanergy (including the investment in the PIPE) has a historical cost basis of $57.5 million. The fair value of the Warrants was determined to be equal to their intrinsic value at closing of the SPAC Merger in accordance with the guidance in FASB ASC Topic 815, Derivatives and Hedging . At closing of the SPAC Merger, the common shares underlying the Warrants were valued at $7.05 per share (the closing market price on February 8, 2022). The intrinsic value of the Warrants, reflecting the $0.01 exercise price, was $17.6 million, which was recorded as deferred income. The following table presents a summary of our investment in Quanergy, presented in other assets on our condensed consolidated balance sheets, at certain dates since December 31, 2021: As of September 30, June 30, February 8, December 31, Price per share (1) $ 0.21 $ 0.41 $ 7.05 N/A Total shares of Quanergy held, including Warrants (in millions) (1) 8.25 8.25 8.25 N/A Series B Investment $ — $ — $ — $ 50,000 Common shares (2) 1,553 3,075 50,000 — PIPE investment 155 308 7,500 — Warrants (2) — — 17,600 — Total equity investment in Quanergy $ 1,708 $ 3,383 $ 75,100 $ 50,000 ___________________________________ (1) Represents common share price and shares held, unadjusted for a 1-to-20 reverse stock split effective after market close on October 6, 2022. Upon execution of the reverse stock split, our holdings of Quanergy common stock (including the PIPE investment) declined to approximately 0.4 million shares, with no impact on fair value. The split-adjusted stock price after close of business on September 30, 2022 was $4.14 per share. Beginning October 7, 2022, Quanergy common stock began trading on a split-adjusted basis. (2) In the three months ended June 30, 2022, we converted the Warrants into common shares. Accordingly, as of September 30, 2022, we had 7.5 million common shares outstanding (excluding the PIPE investment), compared to 5.0 million common shares outstanding as of February 8, 2022. The following table presents a summary of recorded losses related to our equity investment in Quanergy, presented in other, net on our condensed consolidated statements of operations: For the three months ended September 30, 2022 For the nine months ended September 30, 2022 Mark-to-market loss $ (1,675) $ (73,392) As noted above, in exchange for the Warrants, we entered into the Support Agreement, whereby we agreed to provide technical and business development services to Quanergy for a term of four years from the effective date of February 8, 2022. This transaction is an exchange of noncash consideration for services and was accounted for under FASB ASC Topic 845, Nonmonetary Transactions , using the fair value of the Warrants at February 8, 2022 ($17.6 million) as the measure of compensation received. We have deferred this consideration and are recognizing it in earnings on a straight-line basis over the term of the agreement (48 months). Measured on a Nonrecurring Basis We evaluated our goodwill and other indefinite-lived intangible assets for impairment as of October 1, 2021 and determined that they were not impaired. No events or changes in circumstances occurred in the nine months ended September 30, 2022 that would have triggered the need for an additional impairment review of our goodwill and other indefinite-lived intangible assets. In July 2022, we sold various assets and liabilities comprising our semiconductor test and thermal business (collectively, the “Qinex Business”). Refer to Note 16: Acquisitions and Divestitures for additional information. We allocated goodwill to the Qinex Business based on its fair value relative to the total fair value of the Industrial Solutions reporting unit. Financial Instruments Not Recorded at Fair Value The following table presents the carrying values and fair values of financial instruments not recorded at fair value in the condensed consolidated balance sheets as of September 30, 2022 and December 31, 2021. All fair value measures presented are categorized in Level 2 of the fair value hierarchy. September 30, 2022 December 31, 2021 Carrying Value (1) Fair Value Carrying Value (1) Fair Value Liabilities Term Loan $ 447,992 $ 444,632 $ 451,465 $ 450,901 4.875% Senior Notes $ — $ — $ 500,000 $ 526,250 5.625% Senior Notes $ 400,000 $ 394,000 $ 400,000 $ 438,000 5.0% Senior Notes $ 700,000 $ 661,500 $ 700,000 $ 759,500 4.375% Senior Notes $ 450,000 $ 373,500 $ 450,000 $ 479,250 3.75% Senior Notes $ 750,000 $ 579,375 $ 750,000 $ 747,188 4.0% Senior Notes $ 1,000,000 $ 820,000 $ 1,000,000 $ 1,022,500 5.875% Senior Notes $ 500,000 $ 463,750 $ — $ — ___________________________________ (1) Excluding any related debt discounts, premiums, and deferred financing costs. Cash and cash equivalents are carried at cost, which approximates fair value because of their short-term nature. In addition to the above, we hold certain equity investments that do not have readily determinable fair values for which we use the measurement alternative prescribed in FASB ASC Topic 321. There were no impairments or changes resulting from observable transactions for any of these investments and no adjustments were made to their carrying values. Refer to the table below for the carrying values of equity investments using the measurement alternative, which are presented as a component of other assets in the condensed consolidated balance sheets. September 30, December 31, Quanergy Systems, Inc. (1) $ — $ 50,000 Other 15,000 15,000 Total $ 15,000 $ 65,000 ___________________________________ (1) As of September 30, 2022, Quanergy is no longer classified as an equity investment without a readily determinable fair value. See additional discussion under the heading Quanergy elsewhere in this Note.

Derivative Instruments and Hedg

Derivative Instruments and Hedging Activities	9 Months Ended
	Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging Activities	Derivative Instruments and Hedging Activities Hedges of Foreign Currency Risk For the three and nine months ended September 30, 2022 and 2021, amounts excluded from the assessment of effectiveness of our foreign currency forward contracts that are designated as cash flow hedges were not material. As of September 30, 2022, we estimated that $46.4 million of net gains will be reclassified from accumulated other comprehensive income/(loss) to earnings during the twelve-month period ending September 30, 2023. As of September 30, 2022, we had the following outstanding foreign currency forward contracts: Notional Effective Date(s) Maturity Date(s) Index (Exchange Rates) Weighted-Average Strike Rate Hedge Designation (1) 32.0 EUR September 28, 2022 October 31, 2022 Euro ("EUR") to USD 0.96 USD Not designated 364.7 EUR Various from October 2020 to September 2022 Various from October 2022 to September 2024 EUR to USD 1.13 USD Cash flow hedge 471.0 CNY September 27, 2022 October 31, 2022 USD to Chinese Renminbi ("CNY") 7.14 CNY Not designated 378.1 CNY Various from October 2021 to March 2022 Various from October to December 2022 USD to CNY 6.47 CNY Cash flow hedge 21,673.3 KRW Various from November 2020 to September 2022 Various from October 2022 to August 2024 USD to Korean Won ("KRW") 1,208.00 KRW Cash flow hedge 23.0 MYR September 27, 2022 October 31, 2022 USD to Malaysian Ringgit ("MYR") 4.63 MYR Not designated 266.0 MXN September 28, 2022 October 31, 2022 USD to Mexican Peso ("MXN") 20.43 MXN Not designated 3,525.3 MXN Various from October 2020 to September 2022 Various from October 2022 to September 2024 USD to MXN 22.20 MXN Cash flow hedge 10.0 GBP September 28, 2022 October 31, 2022 British Pound Sterling ("GBP") to USD 1.06 USD Not Designated 60.2 GBP Various from October 2020 to September 2022 Various from October 2022 to September 2024 GBP to USD 1.29 USD Cash flow hedge ___________________________________ (1) Derivative financial instruments not designated as hedges are used to manage our exposure to currency exchange rate risk. They are intended to preserve economic value, and they are not used for trading or speculative purposes. Hedges of Commodity Risk As of September 30, 2022, we had the following outstanding commodity forward contracts, none of which were designated for hedge accounting treatment in accordance with FASB ASC Topic 815: Commodity Notional Remaining Contracted Periods Weighted-Average Strike Price Per Unit Silver 983,717 troy oz. October 2022 to July 2024 $23.89 Gold 7,757 troy oz. October 2022 to July 2024 $1,861.62 Nickel 255,206 pounds October 2022 to July 2024 $10.27 Aluminum 4,225,448 pounds October 2022 to July 2024 $1.23 Copper 8,124,126 pounds October 2022 to July 2024 $4.23 Platinum 11,503 troy oz. October 2022 to July 2024 $1,000.80 Palladium 1,340 troy oz. October 2022 to July 2024 $2,291.99 Financial Instrument Presentation The following table presents the fair values of our derivative financial instruments and their classification in the condensed consolidated balance sheets as of September 30, 2022 and December 31, 2021: Asset Derivatives Liability Derivatives Balance Sheet Location September 30, December 31, Balance Sheet Location September 30, December 31, Derivatives designated as hedging instruments Foreign currency forward contracts Prepaid expenses and other current assets $ 55,457 $ 20,562 Accrued expenses and other current liabilities $ 9,630 $ 1,981 Foreign currency forward contracts Other assets 10,251 4,391 Other long-term liabilities 2,651 904 Total $ 65,708 $ 24,953 $ 12,281 $ 2,885 Derivatives not designated as hedging instruments Commodity forward contracts Prepaid expenses and other current assets $ 218 $ 2,583 Accrued expenses and other current liabilities $ 11,338 $ 3,422 Commodity forward contracts Other assets 85 396 Other long-term liabilities 2,959 1,070 Foreign currency forward contracts Prepaid expenses and other current assets 100 159 Accrued expenses and other current liabilities 806 188 Total $ 403 $ 3,138 $ 15,103 $ 4,680 These fair value measurements were all categorized within Level 2 of the fair value hierarchy. The following tables present the effect of our derivative financial instruments on the condensed consolidated statements of operations and the condensed consolidated statements of comprehensive income for the three months ended September 30, 2022 and 2021: Derivatives designated as Amount of Deferred Gain/(Loss) Recognized in Other Comprehensive Income Location of Net Gain/(Loss) Reclassified from Accumulated Other Comprehensive Income/(Loss) into Net Income Amount of Net Gain/(Loss) Reclassified from Accumulated Other Comprehensive Income/(Loss) into Net Income 2022 2021 2022 2021 Foreign currency forward contracts $ 35,324 $ 9,379 Net revenue $ 14,909 $ (1,976) Foreign currency forward contracts $ (5,204) $ (3,832) Cost of revenue $ 1,260 $ 3,557 Derivatives not designated as Amount of (Loss)/Gain Recognized in Net Income Location of (Loss)/Gain Recognized in Net Income 2022 2021 Commodity forward contracts $ (5,773) $ (6,495) Other, net Foreign currency forward contracts $ 6,178 $ (2,414) Other, net The following tables present the effect of our derivative financial instruments on the condensed consolidated statements of operations and the condensed consolidated statements of comprehensive income for the nine months ended September 30, 2022 and 2021: Derivatives designated as Amount of Deferred Gain/(Loss) Recognized in Other Comprehensive Income Location of Net Gain/(Loss) Reclassified from Accumulated Other Comprehensive Income/(Loss) into Net Income Amount of Net Gain/(Loss) Reclassified from Accumulated Other Comprehensive Income/(Loss) into Net Income 2022 2021 2022 2021 Foreign currency forward contracts $ 69,102 $ 21,825 Net revenue $ 28,649 $ (9,816) Foreign currency forward contracts $ (3,824) $ (449) Cost of revenue $ 6,492 $ 6,324 Derivatives not designated as Amount of (Loss)/Gain Recognized in Net Income Location of (Loss)/Gain Recognized in Net Income 2022 2021 Commodity forward contracts $ (14,603) $ (6,462) Other, net Foreign currency forward contracts $ 8,100 $ (4,791) Other, net Credit Risk Related Contingent Features We have agreements with our derivative counterparties that contain a provision whereby if we default on our indebtedness and repayment of the indebtedness has been accelerated by the lender, then we could also be declared in default on our derivative obligations.

Acquisitions and Divestitures

Acquisitions and Divestitures	9 Months Ended
	Sep. 30, 2022
Business Acquisitions and Divestitures [Abstract]
Acquisitions and Divestitures	Acquisitions and Divestitures Acquisitions Spear Power Systems On November 19, 2021, we acquired all of the equity interests of Spear Power Systems ("Spear"), a leader in electrification solutions that supports our newly-established Clean Energy Solutions business unit, for an aggregate purchase price of $113.7 million, subject to certain post-closing items, including a contingent consideration arrangement whereby we may be required to pay up to an additional $30.0 million to the selling shareholders. Using a present value technique, we estimated the acquisition-date fair value of the contingent consideration arrangement to be $8.6 million, which is reflected in the aggregate purchase price. As of September 30, 2022, having evaluated updated financial forecasts, and have determined that the fair value of the contingent consideration arrangement as of September 30, 2022 is $0.0 million, which is unchanged from its fair value as of June 30, 2022. Accordingly, a gain of $8.6 million for the nine months ended September 30, 2022 was recognized in earnings and presented in restructuring and other charges, net. We are integrating Spear into the Sensing Solutions reportable segment. As of September 30, 2022, the allocation of purchase price of Spear is preliminary and is based on management's judgments after evaluating several factors, including preliminary valuation assessments of tangible and intangible assets. The final allocation of the purchase price to the assets acquired will be completed when the final valuations are completed. Refer to Note 21: Acquisitions of the audited consolidated financial statements and notes thereto included in our 2021 Annual Report for detailed information regarding the preliminary allocation of the purchase price to the estimated fair values of the assets acquired and liabilities assumed as of December 31, 2021. SmartWitness Holdings, Inc. On November 19, 2021, we acquired all of the equity interests of SmartWitness Holdings, Inc. ("SmartWitness"), a privately held innovator of video telematics technology for heavy- and light-duty fleets, for an aggregate purchase price of $206.4 million, including $204.2 million of cash paid at closing, subject to certain post-closing items. In addition to the aggregate purchase price, we paid $8.6 million of cash at closing related to an employee retention arrangement. We are integrating SmartWitness into the Performance Sensing reportable segment. As of September 30, 2022, the allocation of purchase price of SmartWitness is preliminary and is based on management's judgments after evaluating several factors, including preliminary valuation assessments of tangible and intangible assets. The final allocation of the purchase price to the assets acquired will be completed when the final valuations are completed. Refer to Note 21: Acquisitions of the audited consolidated financial statements and notes thereto included in our 2021 Annual Report for detailed information regarding the preliminary allocation of the purchase price to the estimated fair values of the assets acquired and liabilities assumed as of December 31, 2021. Elastic M2M Inc. On February 11, 2022, we acquired all of the equity interests of Elastic M2M Inc. ("Elastic M2M") for an aggregate cash purchase price of $51.6 million, subject to certain post-closing items. In addition to the aggregate cash purchase price, the previous shareholders of Elastic M2M are entitled to up to $30.0 million of additional acquisition-related incentive compensation, pending the completion of certain technical milestones in fiscal year 2022 and achievement of financial targets in fiscal years 2022 and 2023. In three and nine months ended September 30, 2022, we recognized $2.0 million and $20.4 million, respectively, of that acquisition-related incentive compensation. This incentive compensation is recorded in restructuring and other charges, net. We paid $15.0 million of this acquisition-related incentive compensation in the nine months ended September 30, 2022, which is reflected as an operating cash outflow on our condensed consolidated statement of cash flows. Elastic M2M is a privately-held innovator of connected intelligence for operational assets across heavy-duty transport, warehouse, supply chain and logistics, industrial, light-duty passenger car, and a variety of other industry segments. Elastic M2M primarily serves telematics service providers and resellers, enabling them to leverage Elastic M2M’s cloud platform and analytics capabilities to deliver sensor-based operational insights to their end users. This acquisition augments our cloud capabilities critical to delivering actionable sensor-based insights, an increasingly important capability in this fast-growing industry segment. We are integrating Elastic M2M into the Performance Sensing reportable segment. The following table summarizes the preliminary allocation of the purchase price to the estimated fair values of the assets acquired and liabilities assumed: Net working capital, excluding cash $ 35 Goodwill 24,708 Other intangible assets 33,500 Deferred income tax liabilities (8,222) Fair value of net assets acquired, excluding cash and cash equivalents 50,021 Cash and cash equivalents 1,597 Fair value of net assets acquired $ 51,618 The allocation of purchase price of Elastic M2M is preliminary and is based on management’s judgments after evaluating several factors, including preliminary valuation assessments of intangible assets. The final allocation of the purchase price to the assets acquired will be completed when the final valuations are completed. The preliminary goodwill of $24.7 million recognized as a result of this acquisition represents future economic benefits expected to arise from synergies from combining operations and the extension of existing customer relationships. The goodwill recognized in this acquisition will not be deductible for tax purposes. In connection with the preliminary allocation of purchase price to the assets acquired and liabilities assumed, we identified certain definite-lived intangible assets. The following table presents the acquired intangible assets, their preliminary estimated fair values, and weighted-average lives: Acquisition Date Fair Value Weighted-Average Lives (years) Acquired definite-lived intangible assets Customer relationships $ 23,300 13 Completed technologies 10,200 10 Total definite-lived intangible assets acquired $ 33,500 12 The definite-lived intangible assets were valued using the income approach. We primarily used the relief-from-royalty method to value completed technologies, and we used the multi-period excess earnings method to value customer relationships. These valuation methods incorporate assumptions including expected discounted future net cash flows resulting from either the future estimated after-tax royalty payments avoided as a result of owning the completed technologies or the future earnings related to existing customer relationships. Dynapower On July 12, 2022, we completed the acquisition of all of the outstanding equity interests of DP Acquisition Corp ("Dynapower"), a leader in power conversion systems including inverters, converters, and rectifiers for renewable energy generation, green hydrogen production, electric vehicle charging stations, and microgrid applications, as well as industrial and defense applications, for an aggregate cash purchase price of $577.7 million, subject to certain post-closing items. Dynapower also provides aftermarket sales and service to maintain its equipment in the field. Dynapower will be a foundational addition to our Clean Energy Solutions strategy and will complement our recent acquisitions of GIGAVAC, Lithium Balance, and Spear. We are integrating Dynapower into our Sensing Solutions reportable segment. The following table summarizes the preliminary allocation of the purchase price to the estimated fair values of the assets acquired and liabilities assumed: Net working capital, excluding cash $ 25,333 Goodwill 357,380 Other intangible assets 229,100 Net long-term other liabilities (38,483) Fair value of net assets acquired, excluding cash and cash equivalents 573,330 Cash and cash equivalents 4,410 Fair value of net assets acquired $ 577,740 The allocation of purchase price of Dynapower is preliminary and is based on management’s judgments after evaluating several factors, including preliminary valuation assessments of intangible assets. The final allocation of the purchase price to the assets acquired will be completed when the final valuations are completed. The preliminary goodwill recognized as a result of this acquisition was approximately $357.4 million, which represents future economic benefits expected to arise from synergies from combining operations and the extension of existing customer relationships. The goodwill recognized in this acquisition will not be deductible for tax purposes. In connection with the preliminary allocation of purchase price to the assets acquired and liabilities assumed, we identified certain definite-lived intangible assets. The following table presents the acquired intangible assets, their estimated fair values, and weighted-average lives: Acquisition Date Fair Value Weighted-Average Lives (years) Acquired definite-lived intangible assets Customer relationships $ 145,600 11 Completed technologies 75,700 10 Tradenames 7,800 10 Total definite-lived intangible assets acquired $ 229,100 11 The definite-lived intangible assets were valued using the income approach. We primarily used the relief-from-royalty method to value completed technologies and tradenames, and we used the multi-period excess earnings method to value customer relationships. These valuation methods incorporate assumptions including expected discounted future net cash flows resulting from either the future estimated after-tax royalty payments avoided as a result of owning the completed technologies or the future earnings related to existing customer relationships. Divestiture - Qinex Business On May 27, 2022, we executed an asset purchase agreement (the "APA") whereby we agreed to sell the Qinex Business to LTI Holdi ngs, Inc. ("LTI") in exchange for consideration of approximately $219.0 million, subject to working capital and other adjustments. Concurrent with the execution of the APA, the parties entered into a Contract Manufacturing Agreement ("CMA") and a Transition Services Agreement ("TSA"), each for nominal consideration. The CMA commenced at closing of the transaction ("Closing") and has a term of either six Closing occurred in July 2022, at which time assets of approximately $70 million (including allocated goodwill of $45 million) and liabilities of approximately $2 million transferred to LTI. Transferred assets and liabilities excluded inventories and accounts payable, which will transfer to LTI at the end of the Transition Peri od. We received cash consideration of $198.8 million at Closing, which is presented as an investing cash flow for the nine months ended September 30, 2022. Cash consideration received at Closing excludes amounts held in escrow until various milestones are met through the Transition Period. We received an additional $5.0 million in August 2022 following fulfillment of a portion of our TSA obligations, which is presented as an operating cash inflow. In the three months ended September 30, 2022, we recognized a pre-tax gain of approximately $135.1 million. In the three and nine months ended September 30, 2022, we recognized approximately $13.5 million and $15.6 million, respectively, of transaction-related charges to sell the Qinex Business. Each of the gain on sale and transaction costs are presented in restructuring and other charges, net in our condensed consolidated statements of operations for the three and nine months ended September 30, 2022. Refer to Note 5: Restructuring and Other Charges, Net .

Segment Reporting

Segment Reporting	9 Months Ended
	Sep. 30, 2022
Segment Reporting [Abstract]
Segment Reporting	Segment Reporting We present financial information for two reportable segments, Performance Sensing and Sensing Solutions. The Performance Sensing reportable segment consists of two operating segments, Automotive and HVOR, which meet the criteria for aggregation in FASB ASC Topic 280, Segment Reporting . The Sensing Solutions reportable segment is also an operating segment. Our operating segments are businesses that we manage as components of an enterprise, for which separate financial information is evaluated regularly by our chief operating decision maker in deciding how to allocate resources and assess performance. An operating segment’s performance is primarily evaluated based on segment operating income, which excludes amortization of intangible assets, restructuring and other charges, net, certain costs associated with our strategic megatrend initiatives, and certain corporate costs or credits not associated with the operations of the segment, including share-based compensation expense and a portion of depreciation expense associated with assets recognized in connection with acquisitions. Corporate and other costs excluded from an operating (and reportable) segment’s performance are separately stated below and also include costs that are related to functional areas such as finance, information technology, legal, and human resources. We believe that segment operating income, as defined above, is an appropriate measure for evaluating the operating performance of our segments. However, this measure should be considered in addition to, and not as a substitute for, or superior to, operating income or other measures of financial performance prepared in accordance with U.S. GAAP. The accounting policies of each of our operating and reportable segments are materially consistent with those described in Note 2: Significant Accounting Policies of the audited consolidated financial statements and notes thereto included in our 2021 Annual Report. The following table presents net revenue and segment operating income for our reportable segments and other operating results not allocated to our reportable segments for the three and nine months ended September 30, 2022 and 2021: For the three months ended For the nine months ended September 30, 2022 September 30, 2021 September 30, 2022 September 30, 2021 Net revenue: Performance Sensing $ 754,527 $ 706,466 $ 2,219,106 $ 2,162,830 Sensing Solutions 263,741 244,555 795,480 723,379 Total net revenue $ 1,018,268 $ 951,021 $ 3,014,586 $ 2,886,209 Segment operating income (as defined above): Performance Sensing $ 188,560 $ 193,742 $ 554,717 $ 591,650 Sensing Solutions 73,622 75,262 225,625 218,705 Total segment operating income 262,182 269,004 780,342 810,355 Corporate and other (76,409) (72,749) (228,894) (215,359) Amortization of intangible assets (40,313) (34,571) (114,485) (101,492) Restructuring and other charges, net 107,441 (345) 80,811 (9,956) Operating income 252,901 161,339 517,774 483,548 Interest expense, net (44,856) (45,137) (135,143) (134,393) Other, net (21,371) (9,403) (111,067) (47,788) Income before taxes $ 186,674 $ 106,799 $ 271,564 $ 301,367

Basis of Presentation (Policies

Basis of Presentation (Policies)	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States ("U.S.") generally accepted accounting principles ("GAAP") for interim financial information and the instructions to Form 10-Q. Accordingly, these interim financial statements do not include all of the information and note disclosures required by U.S. GAAP for complete financial statements. The accompanying financial information reflects all normal recurring adjustments that are, in the opinion of management, necessary for a fair presentation of the interim period results. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2021 filed with the U.S. Securities and Exchange Commission (the "SEC") on February 10, 2022 (the "2021 Annual Report"). All U.S. dollar ("USD") and share amounts presented, except per share amounts, are stated in thousands, unless otherwise indicated. Certain reclassifications have been made to prior periods to conform to current period presentation.

Revenue Recognition (Tables)

Revenue Recognition (Tables)	9 Months Ended
	Sep. 30, 2022
Revenue Recognition and Deferred Revenue [Abstract]
Schedule of Disaggregation of Revenue	The following table presents net revenue disaggregated by segment and end market for the three and nine months ended September 30, 2022 and 2021: For the three months ended September 30, 2022 For the three months ended September 30, 2021 Performance Sensing Sensing Solutions Total Performance Sensing Sensing Solutions Total Automotive $ 525,271 $ 8,616 $ 533,887 $ 488,041 $ 9,451 $ 497,492 HVOR (1) 229,256 — 229,256 218,425 — 218,425 Industrial — 147,191 147,191 — 106,809 106,809 Appliance and HVAC (2) — 51,927 51,927 — 62,793 62,793 Aerospace — 37,789 37,789 — 34,377 34,377 Other — 18,218 18,218 — 31,125 31,125 Total $ 754,527 $ 263,741 $ 1,018,268 $ 706,466 $ 244,555 $ 951,021 ___________________________________ (1) Heavy vehicle and off-road (2) Heating, ventilation and air conditioning For the nine months ended September 30, 2022 For the nine months ended September 30, 2021 Performance Sensing Sensing Solutions Total Performance Sensing Sensing Solutions Total Automotive $ 1,533,865 $ 27,833 $ 1,561,698 $ 1,543,121 $ 33,003 $ 1,576,124 HVOR 685,241 — 685,241 619,709 — 619,709 Industrial — 385,470 385,470 — 302,758 302,758 Appliance and HVAC — 168,427 168,427 — 185,896 185,896 Aerospace — 109,617 109,617 — 99,847 99,847 Other — 104,133 104,133 — 101,875 101,875 Total $ 2,219,106 $ 795,480 $ 3,014,586 $ 2,162,830 $ 723,379 $ 2,886,209

Share-Based Payment Plans (Tabl

Share-Based Payment Plans (Tables)	9 Months Ended
	Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]
Schedule of Non-Cash Compensation Expense Related to Equity Awards	The following table presents the components of non-cash compensation expense related to our equity awards for the three and nine months ended September 30, 2022 and 2021: For the three months ended For the nine months ended September 30, 2022 September 30, 2021 September 30, 2022 September 30, 2021 Stock options $ 158 $ 307 $ 467 $ 1,072 Restricted securities 8,283 7,089 23,713 17,799 Share-based compensation expense $ 8,441 $ 7,396 $ 24,180 $ 18,871
Share-Based Payment Arrangement, Restricted Stock Unit, Activity	We granted the following restricted stock units ("RSUs" and each, an "RSU") and performance-based restricted stock units ("PRSUs" and each, a "PRSU") under the Sensata Technologies Holding plc 2021 Equity Incentive Plan during the nine months ended September 30, 2022: Awards Granted To: Type of Award Number of Units Granted (in thousands) Percentage of PRSUs Awarded that May Vest Weighted Average Grant Date Fair Value Directors RSU (1) 29 N/A $ 46.30 Various executives and employees RSU (2) 583 N/A $ 49.97 Various executives and employees PRSU (3) 420 0.0% - 200.0% $ 49.45 ____________________________________ (1) These RSUs cliff vest one year from the grant date (May 2023). (2) These RSUs vest ratably over three years, one-third per year beginning on the first anniversary of the grant date. These RSUs will fully vest on various dates between January 2025 and September 2025. (3) These PRSUs vest on various dates between April 2025 and September 2025. The number of units that ultimately vest is dependent on the achievement of certain performance criteria.

Restructuring and Other Charg_2

Restructuring and Other Charges, Net (Tables)	9 Months Ended
	Sep. 30, 2022
Restructuring and Related Activities [Abstract]
Schedule of Restructuring and Other Charges, Net	The following table presents the components of restructuring and other charges, net for the three and nine months ended September 30, 2022 and 2021: For the three months ended For the nine months ended September 30, 2022 September 30, 2021 September 30, 2022 September 30, 2021 Q2 2020 Global Restructure Program charges $ — $ 3,098 $ — $ 8,752 Other restructuring and other charges, net Severance costs, net 6,249 133 6,836 726 Facility and other exit costs 2,181 541 4,470 1,832 Gain on sale of Qinex Business (135,112) — (135,112) — Acquisition-related compensation arrangements 7,359 — 38,448 — Other (1) 11,882 (3,427) 4,547 (1,354) Restructuring and other charges, net $ (107,441) $ 345 $ (80,811) $ 9,956 ___________________________________ (1) Primarily includes, in the three and nine months ended September 30, 2022, transaction-related charges to sell the Qinex Business, partially offset in the nine months ended September 30, 2022 by gains related to changes in the fair value of acquisition-related contingent consideration amounts. Refer to Note 16: Acquisitions and Divestitures for additional information.
Schedule of Changes to Restructuring Liability	The following table presents a rollforward of the severance portion of our restructuring obligations for the nine months ended September 30, 2022. Q2 2020 Global Restructure Program Other Total Balance as of December 31, 2021 $ 3,853 $ 3,380 $ 7,233 Charges, net of reversals — 6,836 6,836 Payments (3,129) (2,323) (5,452) Foreign currency remeasurement (90) (281) (371) Balance as of September 30, 2022 $ 634 $ 7,612 $ 8,246

Other, Net (Tables)

Other, Net (Tables)	9 Months Ended
	Sep. 30, 2022
Other Income and Expenses [Abstract]
Schedule of Other, Net	The following table presents the components of other, net for the three and nine months ended September 30, 2022 and 2021: For the three months ended For the nine months ended September 30, 2022 September 30, 2021 September 30, 2022 September 30, 2021 Currency remeasurement (loss)/gain on net monetary assets $ (12,583) $ (324) $ (26,740) $ 187 Gain/(loss) on foreign currency forward contracts 6,178 (2,414) 8,100 (4,791) Loss on commodity forward contracts (5,773) (6,495) (14,603) (6,462) Loss on debt financing (5,468) — (5,468) (30,066) Mark-to-market loss on investments, net (4,035) — (75,135) — Net periodic benefit cost, excluding service cost (868) (1,053) (2,262) (5,731) Other 1,178 883 5,041 (925) Other, net $ (21,371) $ (9,403) $ (111,067) $ (47,788)

Income Taxes (Tables)

Income Taxes (Tables)	9 Months Ended
	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Schedule of Provision for Income Taxes	The following table presents the provision for income taxes for the three and nine months ended September 30, 2022 and 2021: For the three months ended For the nine months ended September 30, 2022 September 30, 2021 September 30, 2022 September 30, 2021 Provision for income taxes $ 46,421 $ 21,840 $ 74,029 $ 49,759

Net Income per Share (Tables)

Net Income per Share (Tables)	9 Months Ended
	Sep. 30, 2022
Earnings Per Share [Abstract]
Schedule of Weighted-Average Ordinary Shares Outstanding	For the three and nine months ended September 30, 2022 and 2021 the weighted-average ordinary shares outstanding used to calculate basic and diluted net income per share were as follows: For the three months ended For the nine months ended September 30, 2022 September 30, 2021 September 30, 2022 September 30, 2021 Basic weighted-average ordinary shares outstanding 154,474 158,394 156,124 158,122 Dilutive effect of stock options 107 603 256 660 Dilutive effect of unvested restricted securities 362 482 475 569 Diluted weighted-average ordinary shares outstanding 154,943 159,479 156,855 159,351
Schedule of Antidilutive Securities	These potential ordinary shares were as follows: For the three months ended For the nine months ended September 30, 2022 September 30, 2021 September 30, 2022 September 30, 2021 Anti-dilutive shares excluded 1,917 9 1,116 8 Contingently issuable shares excluded 1,513 1,072 1,299 1,037

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Sep. 30, 2022
Inventory Disclosure [Abstract]
Schedule of Components of Inventories	The following table presents the components of inventories as of September 30, 2022 and December 31, 2021: September 30, December 31, Finished goods $ 223,607 $ 201,424 Work-in-process 111,823 101,558 Raw materials 340,432 285,249 Inventories $ 675,862 $ 588,231

Pension and Other Post-Retire_2

Pension and Other Post-Retirement Benefits (Tables)	9 Months Ended
	Sep. 30, 2022
Retirement Benefits [Abstract]
Schedule of Components of Net Periodic Benefit Cost (Credit)	The following table presents the components of net periodic benefit cost/(credit) associated with our defined benefit and retiree healthcare plans for the three months ended September 30, 2022 and 2021: U.S. Plans Non-U.S. Plans Defined Benefit Retiree Healthcare Defined Benefit Total 2022 2021 2022 2021 2022 2021 2022 2021 Service cost $ — $ — $ 2 $ 2 $ 958 $ 725 $ 960 $ 727 Interest cost 113 167 22 21 417 405 552 593 Expected return on plan assets (195) (226) — — (214) (177) (409) (403) Amortization of net loss/(gain) 226 243 (43) — 327 461 510 704 Amortization of prior service (credit)/cost — — (100) (159) 2 3 (98) (156) Loss on settlement 313 315 — — — — 313 315 Net periodic benefit cost/(credit) $ 457 $ 499 $ (119) $ (136) $ 1,490 $ 1,417 $ 1,828 $ 1,780 The following table presents the components of net periodic benefit cost/(credit) associated with our defined benefit and retiree healthcare plans for the nine months ended September 30, 2022 and 2021: U.S. Plans Non-U.S. Plans Defined Benefit Retiree Healthcare Defined Benefit Total 2022 2021 2022 2021 2022 2021 2022 2021 Service cost $ — $ — $ 6 $ 6 $ 2,896 $ 3,028 $ 2,902 $ 3,034 Interest cost 339 407 86 63 1,267 1,210 1,692 1,680 Expected return on plan assets (585) (678) — — (700) (534) (1,285) (1,212) Amortization of net loss/(gain) 593 1,045 (86) — 935 1,382 1,442 2,427 Amortization of prior service (credit)/cost — — (300) (477) 7 19 (293) (458) Loss on settlement 706 3,294 — — — — 706 3,294 Net periodic benefit cost/(credit) $ 1,053 $ 4,068 $ (294) $ (408) $ 4,405 $ 5,105 $ 5,164 $ 8,765

Debt (Tables)

Debt (Tables)	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Schedule of Long-term Debt, Finance Lease, and Other Financing Obligations	The following table presents the components of long-term debt, finance lease and other financing obligations as of September 30, 2022 and December 31, 2021: Maturity Date September 30, December 31, Term Loan September 20, 2026 $ 447,992 $ 451,465 4.875% Senior Notes October 15, 2023 — 500,000 5.625% Senior Notes November 1, 2024 400,000 400,000 5.0% Senior Notes October 1, 2025 700,000 700,000 4.375% Senior Notes February 15, 2030 450,000 450,000 3.75% Senior Notes February 15, 2031 750,000 750,000 4.0% Senior Notes April 15, 2029 1,000,000 1,000,000 5.875% Senior Notes September 1, 2030 500,000 — Less: debt discount, net of premium (3,740) (5,207) Less: deferred financing costs (30,952) (26,682) Less: current portion (4,630) (4,630) Long-term debt, net $ 4,208,670 $ 4,214,946 Finance lease and other financing obligations $ 27,086 $ 28,767 Less: current portion (1,906) (2,203) Finance lease and other financing obligations, less current portion $ 25,180 $ 26,564
Schedule of Debt Instrument Redemption	At any time on or after September 1, 2025, STBV may redeem the 5.875% Senior Notes, in whole or in part, at the following prices (expressed as a percentage of principal amount), plus accrued and unpaid interest, if any, up to but excluding the redemption date: Period beginning September 1, Price 2025 102.398 % 2026 101.469 % 2027 and thereafter 100.000 %

Shareholders' Equity (Tables)

Shareholders' Equity (Tables)	9 Months Ended
	Sep. 30, 2022
Equity [Abstract]
Schedule of Roll Forward of Components of Accumulated Other Comprehensive Income (Loss)	The following table presents the components of accumulated other comprehensive income/(loss) for the nine months ended September 30, 2022: Cash Flow Hedges Defined Benefit and Retiree Healthcare Plans Accumulated Other Comprehensive Income/(Loss) Balance as of December 31, 2021 $ 16,831 $ (36,391) $ (19,560) Other comprehensive income before reclassifications, net of tax 48,437 — 48,437 Reclassifications from accumulated other comprehensive income/(loss), net of tax (26,075) 1,385 (24,690) Other comprehensive income 22,362 1,385 23,747 Balance as of September 30, 2022 $ 39,193 $ (35,006) $ 4,187
Schedule of Amounts Reclassified from Accumulated Other Comprehensive Income (Loss)	The following table presents the amounts reclassified from accumulated other comprehensive income/(loss) for the three and nine months ended September 30, 2022 and 2021: For the three months ended September 30, For the nine months ended September 30, Affected Line in Condensed Consolidated Statements of Operations Component 2022 2021 2022 2021 Derivative instruments designated and qualifying as cash flow hedges: Foreign currency forward contracts $ (14,909) $ 1,976 $ (28,649) $ 9,816 Net revenue (1) Foreign currency forward contracts (1,260) (3,557) (6,492) (6,324) Cost of revenue (1) Total, before taxes (16,169) (1,581) (35,141) 3,492 Income before taxes Income tax effect 4,172 395 9,066 (873) Provision for income taxes Total, net of taxes $ (11,997) $ (1,186) $ (26,075) $ 2,619 Net income Defined benefit and retiree healthcare plans $ 725 $ 863 $ 1,855 $ 5,263 Other, net (2) Income tax effect (148) (269) (470) (1,285) Provision for income taxes Total, net of taxes $ 577 $ 594 $ 1,385 $ 3,978 Net income ___________________________________ (1) Refer to Note 15: Derivative Instruments and Hedging Activities for additional information on amounts to be reclassified from accumulated other comprehensive income/(loss) in future periods. (2) Refer to Note 10: Pension and Other Post-Retirement Benefits for additional information on net periodic benefit cost/(credit).

Fair Value Measures (Tables)

Fair Value Measures (Tables)	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis	The fair values of our derivative assets and liabilities measured at fair value on a recurring basis as of September 30, 2022 and December 31, 2021 are shown in the below table. All fair value measures presented are categorized in Level 2 of the fair value hierarchy. September 30, December 31, Assets Foreign currency forward contracts $ 65,808 $ 25,112 Commodity forward contracts 303 2,979 Total $ 66,111 $ 28,091 Liabilities Foreign currency forward contracts $ 13,087 $ 3,073 Commodity forward contracts 14,297 4,492 Total $ 27,384 $ 7,565
Schedule of Equity Securities without Readily Determinable Fair Value	The following table presents a summary of our investment in Quanergy, presented in other assets on our condensed consolidated balance sheets, at certain dates since December 31, 2021: As of September 30, June 30, February 8, December 31, Price per share (1) $ 0.21 $ 0.41 $ 7.05 N/A Total shares of Quanergy held, including Warrants (in millions) (1) 8.25 8.25 8.25 N/A Series B Investment $ — $ — $ — $ 50,000 Common shares (2) 1,553 3,075 50,000 — PIPE investment 155 308 7,500 — Warrants (2) — — 17,600 — Total equity investment in Quanergy $ 1,708 $ 3,383 $ 75,100 $ 50,000 ___________________________________ (1) Represents common share price and shares held, unadjusted for a 1-to-20 reverse stock split effective after market close on October 6, 2022. Upon execution of the reverse stock split, our holdings of Quanergy common stock (including the PIPE investment) declined to approximately 0.4 million shares, with no impact on fair value. The split-adjusted stock price after close of business on September 30, 2022 was $4.14 per share. Beginning October 7, 2022, Quanergy common stock began trading on a split-adjusted basis. (2) In the three months ended June 30, 2022, we converted the Warrants into common shares. Accordingly, as of September 30, 2022, we had 7.5 million common shares outstanding (excluding the PIPE investment), compared to 5.0 million common shares outstanding as of February 8, 2022. The following table presents a summary of recorded losses related to our equity investment in Quanergy, presented in other, net on our condensed consolidated statements of operations: For the three months ended September 30, 2022 For the nine months ended September 30, 2022 Mark-to-market loss $ (1,675) $ (73,392) Refer to the table below for the carrying values of equity investments using the measurement alternative, which are presented as a component of other assets in the condensed consolidated balance sheets. September 30, December 31, Quanergy Systems, Inc. (1) $ — $ 50,000 Other 15,000 15,000 Total $ 15,000 $ 65,000 ___________________________________ (1) As of September 30, 2022, Quanergy is no longer classified as an equity investment without a readily determinable fair value. See additional discussion under the heading Quanergy elsewhere in this Note.
Schedule of Information about Carrying Values and Fair Values of Financial Instruments not Recorded at Fair Value	The following table presents the carrying values and fair values of financial instruments not recorded at fair value in the condensed consolidated balance sheets as of September 30, 2022 and December 31, 2021. All fair value measures presented are categorized in Level 2 of the fair value hierarchy. September 30, 2022 December 31, 2021 Carrying Value (1) Fair Value Carrying Value (1) Fair Value Liabilities Term Loan $ 447,992 $ 444,632 $ 451,465 $ 450,901 4.875% Senior Notes $ — $ — $ 500,000 $ 526,250 5.625% Senior Notes $ 400,000 $ 394,000 $ 400,000 $ 438,000 5.0% Senior Notes $ 700,000 $ 661,500 $ 700,000 $ 759,500 4.375% Senior Notes $ 450,000 $ 373,500 $ 450,000 $ 479,250 3.75% Senior Notes $ 750,000 $ 579,375 $ 750,000 $ 747,188 4.0% Senior Notes $ 1,000,000 $ 820,000 $ 1,000,000 $ 1,022,500 5.875% Senior Notes $ 500,000 $ 463,750 $ — $ — ___________________________________ (1) Excluding any related debt discounts, premiums, and deferred financing costs.

Derivative Instruments and He_2

Derivative Instruments and Hedging Activities (Tables)	9 Months Ended
	Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Outstanding Derivative Instruments	As of September 30, 2022, we had the following outstanding foreign currency forward contracts: Notional Effective Date(s) Maturity Date(s) Index (Exchange Rates) Weighted-Average Strike Rate Hedge Designation (1) 32.0 EUR September 28, 2022 October 31, 2022 Euro ("EUR") to USD 0.96 USD Not designated 364.7 EUR Various from October 2020 to September 2022 Various from October 2022 to September 2024 EUR to USD 1.13 USD Cash flow hedge 471.0 CNY September 27, 2022 October 31, 2022 USD to Chinese Renminbi ("CNY") 7.14 CNY Not designated 378.1 CNY Various from October 2021 to March 2022 Various from October to December 2022 USD to CNY 6.47 CNY Cash flow hedge 21,673.3 KRW Various from November 2020 to September 2022 Various from October 2022 to August 2024 USD to Korean Won ("KRW") 1,208.00 KRW Cash flow hedge 23.0 MYR September 27, 2022 October 31, 2022 USD to Malaysian Ringgit ("MYR") 4.63 MYR Not designated 266.0 MXN September 28, 2022 October 31, 2022 USD to Mexican Peso ("MXN") 20.43 MXN Not designated 3,525.3 MXN Various from October 2020 to September 2022 Various from October 2022 to September 2024 USD to MXN 22.20 MXN Cash flow hedge 10.0 GBP September 28, 2022 October 31, 2022 British Pound Sterling ("GBP") to USD 1.06 USD Not Designated 60.2 GBP Various from October 2020 to September 2022 Various from October 2022 to September 2024 GBP to USD 1.29 USD Cash flow hedge ___________________________________ (1) Derivative financial instruments not designated as hedges are used to manage our exposure to currency exchange rate risk. They are intended to preserve economic value, and they are not used for trading or speculative purposes. As of September 30, 2022, we had the following outstanding commodity forward contracts, none of which were designated for hedge accounting treatment in accordance with FASB ASC Topic 815: Commodity Notional Remaining Contracted Periods Weighted-Average Strike Price Per Unit Silver 983,717 troy oz. October 2022 to July 2024 $23.89 Gold 7,757 troy oz. October 2022 to July 2024 $1,861.62 Nickel 255,206 pounds October 2022 to July 2024 $10.27 Aluminum 4,225,448 pounds October 2022 to July 2024 $1.23 Copper 8,124,126 pounds October 2022 to July 2024 $4.23 Platinum 11,503 troy oz. October 2022 to July 2024 $1,000.80 Palladium 1,340 troy oz. October 2022 to July 2024 $2,291.99
Schedule of Fair Values of Derivative Financial Instruments and their Classification in Balance Sheets	The following table presents the fair values of our derivative financial instruments and their classification in the condensed consolidated balance sheets as of September 30, 2022 and December 31, 2021: Asset Derivatives Liability Derivatives Balance Sheet Location September 30, December 31, Balance Sheet Location September 30, December 31, Derivatives designated as hedging instruments Foreign currency forward contracts Prepaid expenses and other current assets $ 55,457 $ 20,562 Accrued expenses and other current liabilities $ 9,630 $ 1,981 Foreign currency forward contracts Other assets 10,251 4,391 Other long-term liabilities 2,651 904 Total $ 65,708 $ 24,953 $ 12,281 $ 2,885 Derivatives not designated as hedging instruments Commodity forward contracts Prepaid expenses and other current assets $ 218 $ 2,583 Accrued expenses and other current liabilities $ 11,338 $ 3,422 Commodity forward contracts Other assets 85 396 Other long-term liabilities 2,959 1,070 Foreign currency forward contracts Prepaid expenses and other current assets 100 159 Accrued expenses and other current liabilities 806 188 Total $ 403 $ 3,138 $ 15,103 $ 4,680
Schedule of Effect of Derivative Financial Instruments on Statements of Operations	The following tables present the effect of our derivative financial instruments on the condensed consolidated statements of operations and the condensed consolidated statements of comprehensive income for the three months ended September 30, 2022 and 2021: Derivatives designated as Amount of Deferred Gain/(Loss) Recognized in Other Comprehensive Income Location of Net Gain/(Loss) Reclassified from Accumulated Other Comprehensive Income/(Loss) into Net Income Amount of Net Gain/(Loss) Reclassified from Accumulated Other Comprehensive Income/(Loss) into Net Income 2022 2021 2022 2021 Foreign currency forward contracts $ 35,324 $ 9,379 Net revenue $ 14,909 $ (1,976) Foreign currency forward contracts $ (5,204) $ (3,832) Cost of revenue $ 1,260 $ 3,557 Derivatives not designated as Amount of (Loss)/Gain Recognized in Net Income Location of (Loss)/Gain Recognized in Net Income 2022 2021 Commodity forward contracts $ (5,773) $ (6,495) Other, net Foreign currency forward contracts $ 6,178 $ (2,414) Other, net The following tables present the effect of our derivative financial instruments on the condensed consolidated statements of operations and the condensed consolidated statements of comprehensive income for the nine months ended September 30, 2022 and 2021: Derivatives designated as Amount of Deferred Gain/(Loss) Recognized in Other Comprehensive Income Location of Net Gain/(Loss) Reclassified from Accumulated Other Comprehensive Income/(Loss) into Net Income Amount of Net Gain/(Loss) Reclassified from Accumulated Other Comprehensive Income/(Loss) into Net Income 2022 2021 2022 2021 Foreign currency forward contracts $ 69,102 $ 21,825 Net revenue $ 28,649 $ (9,816) Foreign currency forward contracts $ (3,824) $ (449) Cost of revenue $ 6,492 $ 6,324 Derivatives not designated as Amount of (Loss)/Gain Recognized in Net Income Location of (Loss)/Gain Recognized in Net Income 2022 2021 Commodity forward contracts $ (14,603) $ (6,462) Other, net Foreign currency forward contracts $ 8,100 $ (4,791) Other, net

Acquisitions and Divestitures (

Acquisitions and Divestitures (Tables)	9 Months Ended
	Sep. 30, 2022
Business Acquisitions and Divestitures [Abstract]
Schedule of Fair Values of Assets Acquired and Liabilities Assumed	The following table summarizes the preliminary allocation of the purchase price to the estimated fair values of the assets acquired and liabilities assumed: Net working capital, excluding cash $ 35 Goodwill 24,708 Other intangible assets 33,500 Deferred income tax liabilities (8,222) Fair value of net assets acquired, excluding cash and cash equivalents 50,021 Cash and cash equivalents 1,597 Fair value of net assets acquired $ 51,618 The following table summarizes the preliminary allocation of the purchase price to the estimated fair values of the assets acquired and liabilities assumed: Net working capital, excluding cash $ 25,333 Goodwill 357,380 Other intangible assets 229,100 Net long-term other liabilities (38,483) Fair value of net assets acquired, excluding cash and cash equivalents 573,330 Cash and cash equivalents 4,410 Fair value of net assets acquired $ 577,740
Schedule of Acquired Intangible Assets and Weighted Average Useful Lives	The following table presents the acquired intangible assets, their preliminary estimated fair values, and weighted-average lives: Acquisition Date Fair Value Weighted-Average Lives (years) Acquired definite-lived intangible assets Customer relationships $ 23,300 13 Completed technologies 10,200 10 Total definite-lived intangible assets acquired $ 33,500 12 Acquisition Date Fair Value Weighted-Average Lives (years) Acquired definite-lived intangible assets Customer relationships $ 145,600 11 Completed technologies 75,700 10 Tradenames 7,800 10 Total definite-lived intangible assets acquired $ 229,100 11

Segment Reporting (Tables)

Segment Reporting (Tables)	9 Months Ended
	Sep. 30, 2022
Segment Reporting [Abstract]
Schedule of Segment Reporting Information by Segment	The following table presents net revenue and segment operating income for our reportable segments and other operating results not allocated to our reportable segments for the three and nine months ended September 30, 2022 and 2021: For the three months ended For the nine months ended September 30, 2022 September 30, 2021 September 30, 2022 September 30, 2021 Net revenue: Performance Sensing $ 754,527 $ 706,466 $ 2,219,106 $ 2,162,830 Sensing Solutions 263,741 244,555 795,480 723,379 Total net revenue $ 1,018,268 $ 951,021 $ 3,014,586 $ 2,886,209 Segment operating income (as defined above): Performance Sensing $ 188,560 $ 193,742 $ 554,717 $ 591,650 Sensing Solutions 73,622 75,262 225,625 218,705 Total segment operating income 262,182 269,004 780,342 810,355 Corporate and other (76,409) (72,749) (228,894) (215,359) Amortization of intangible assets (40,313) (34,571) (114,485) (101,492) Restructuring and other charges, net 107,441 (345) 80,811 (9,956) Operating income 252,901 161,339 517,774 483,548 Interest expense, net (44,856) (45,137) (135,143) (134,393) Other, net (21,371) (9,403) (111,067) (47,788) Income before taxes $ 186,674 $ 106,799 $ 271,564 $ 301,367

Revenue Recognition (Details)

Revenue Recognition (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Disaggregation of Revenue [Line Items]
Net revenue	$ 1,018,268	$ 951,021	$ 3,014,586	$ 2,886,209
Performance Sensing
Disaggregation of Revenue [Line Items]
Net revenue	754,527	706,466	2,219,106	2,162,830
Sensing Solutions
Disaggregation of Revenue [Line Items]
Net revenue	263,741	244,555	795,480	723,379
Automotive
Disaggregation of Revenue [Line Items]
Net revenue	533,887	497,492	1,561,698	1,576,124
Automotive | Performance Sensing
Disaggregation of Revenue [Line Items]
Net revenue	525,271	488,041	1,533,865	1,543,121
Automotive | Sensing Solutions
Disaggregation of Revenue [Line Items]
Net revenue	8,616	9,451	27,833	33,003
HVOR
Disaggregation of Revenue [Line Items]
Net revenue	229,256	218,425	685,241	619,709
HVOR | Performance Sensing
Disaggregation of Revenue [Line Items]
Net revenue	229,256	218,425	685,241	619,709
HVOR | Sensing Solutions
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Industrial
Disaggregation of Revenue [Line Items]
Net revenue	147,191	106,809	385,470	302,758
Industrial | Performance Sensing
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Industrial | Sensing Solutions
Disaggregation of Revenue [Line Items]
Net revenue	147,191	106,809	385,470	302,758
Appliance and HVAC
Disaggregation of Revenue [Line Items]
Net revenue	51,927	62,793	168,427	185,896
Appliance and HVAC | Performance Sensing
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Appliance and HVAC | Sensing Solutions
Disaggregation of Revenue [Line Items]
Net revenue	51,927	62,793	168,427	185,896
Aerospace
Disaggregation of Revenue [Line Items]
Net revenue	37,789	34,377	109,617	99,847
Aerospace | Performance Sensing
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Aerospace | Sensing Solutions
Disaggregation of Revenue [Line Items]
Net revenue	37,789	34,377	109,617	99,847
Other
Disaggregation of Revenue [Line Items]
Net revenue	18,218	31,125	104,133	101,875
Other | Performance Sensing
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Other | Sensing Solutions
Disaggregation of Revenue [Line Items]
Net revenue	$ 18,218	$ 31,125	$ 104,133	$ 101,875

Share-Based Payment Plans - Sha

Share-Based Payment Plans - Share-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	$ 8,441	$ 7,396	$ 24,180	$ 18,871
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	158	307	467	1,072
Restricted securities
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	$ 8,283	$ 7,089	$ 23,713	$ 17,799

Share-Based Payment Plans - Equ

Share-Based Payment Plans - Equity Awards (Details) shares in Thousands	9 Months Ended
	Sep. 30, 2022 $ / shares shares
Directors | RSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of units granted (in shares) | shares	29
Weighted-average grant date fair value (in dollars per share) | $ / shares	$ 46.30
Award vesting period	1 year
Various executives and employees | RSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of units granted (in shares) | shares	583
Weighted-average grant date fair value (in dollars per share) | $ / shares	$ 49.97
Award vesting period	3 years
Award vesting percentage	33.33%
Various executives and employees | PRSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of units granted (in shares) | shares	420
Weighted-average grant date fair value (in dollars per share) | $ / shares	$ 49.45
Various executives and employees | PRSU | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of PRSUs Awarded that May Vest	0%
Various executives and employees | PRSU | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of PRSUs Awarded that May Vest	200%

Restructuring and Other Charg_3

Restructuring and Other Charges, Net - Components of Restructuring and Other Charges, Net (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Loss Contingencies [Line Items]
Gain on sale of Qinex Business			$ 135,112	$ 0
Restructuring and other charges, net	$ (107,441)	$ 345	(80,811)	9,956
Q2 2020 Global Restructure Program
Loss Contingencies [Line Items]
Q2 2020 Global Restructure Program charges	0	3,098	0	8,752
Other restructuring and other charges, net
Loss Contingencies [Line Items]
Severance costs, net	6,249	133	6,836	726
Facility and other exit costs	2,181	541	4,470	1,832
Gain on sale of Qinex Business	(135,112)	0	(135,112)	0
Acquisition-related compensation arrangements	7,359	0	38,448	0
Other	$ 11,882	$ (3,427)	$ 4,547	$ (1,354)

Restructuring and Other Charg_4

Restructuring and Other Charges, Net - Schedule of Changes to Restructuring Liability (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Q2 2020 Global Restructure Program
Restructuring Reserve [Roll Forward]
Charges, net of reversals	$ 0	$ 3,098	$ 0	$ 8,752
Employee Severance
Restructuring Reserve [Roll Forward]
Restructuring reserve, beginning balance			7,233
Charges, net of reversals			6,836
Payments			(5,452)
Foreign currency remeasurement			(371)
Restructuring reserve, ending balance	8,246		8,246
Employee Severance | Q2 2020 Global Restructure Program
Restructuring Reserve [Roll Forward]
Restructuring reserve, beginning balance			3,853
Charges, net of reversals			0
Payments			(3,129)
Foreign currency remeasurement			(90)
Restructuring reserve, ending balance	634		634
Employee Severance | Other
Restructuring Reserve [Roll Forward]
Restructuring reserve, beginning balance			3,380
Charges, net of reversals			6,836
Payments			(2,323)
Foreign currency remeasurement			(281)
Restructuring reserve, ending balance	$ 7,612		$ 7,612

Other, Net (Details)

Other, Net (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Other Income and Expenses [Abstract]
Currency remeasurement (loss)/gain on net monetary assets	$ (12,583)	$ (324)	$ (26,740)	$ 187
Gain/(loss) on foreign currency forward contracts	6,178	(2,414)	8,100	(4,791)
Loss on commodity forward contracts	(5,773)	(6,495)	(14,603)	(6,462)
Loss on debt financing	(5,468)	0	(5,468)	(30,066)
Mark-to-market loss on investments, net	(4,035)	0	(75,135)	0
Net periodic benefit cost, excluding service cost	(868)	(1,053)	(2,262)	(5,731)
Other	1,178	883	5,041	(925)
Other, net	$ (21,371)	$ (9,403)	$ (111,067)	$ (47,788)

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 46,421	$ 21,840	$ 74,029	$ 49,759

Net Income per Share - Schedule

Net Income per Share - Schedule of Weighted Average Number of Shares (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Earnings Per Share [Abstract]
Basic weighted-average ordinary shares outstanding (in shares)	154,474	158,394	156,124	158,122
Dilutive effect of stock options (in shares)	107	603	256	660
Dilutive effect of unvested restricted securities (in shares)	362	482	475	569
Diluted weighted-average ordinary shares outstanding (in shares)	154,943	159,479	156,855	159,351

Net Income per Share - Schedu_2

Net Income per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Anti-dilutive shares excluded
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	1,917	9	1,116	8
Contingently issuable shares excluded
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	1,513	1,072	1,299	1,037

Inventories (Details)

Inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Inventory Disclosure [Abstract]
Finished goods	$ 223,607	$ 201,424
Work-in-process	111,823	101,558
Raw materials	340,432	285,249
Inventories	$ 675,862	$ 588,231

Pension and Other Post-Retire_3

Pension and Other Post-Retirement Benefits - Schedule of components of net periodic benefit cost (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]
Service cost	$ 960	$ 727	$ 2,902	$ 3,034
Interest cost	552	593	1,692	1,680
Expected return on plan assets	(409)	(403)	(1,285)	(1,212)
Amortization of net loss/(gain)	510	704	1,442	2,427
Amortization of prior service (credit)/cost	(98)	(156)	(293)	(458)
Loss on settlement	313	315	706	3,294
Net periodic benefit cost/(credit)	1,828	1,780	5,164	8,765
U.S. Plans | Defined Benefit
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]
Service cost	0	0	0	0
Interest cost	113	167	339	407
Expected return on plan assets	(195)	(226)	(585)	(678)
Amortization of net loss/(gain)	226	243	593	1,045
Amortization of prior service (credit)/cost	0	0	0	0
Loss on settlement	313	315	706	3,294
Net periodic benefit cost/(credit)	457	499	1,053	4,068
U.S. Plans | Retiree Healthcare
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]
Service cost	2	2	6	6
Interest cost	22	21	86	63
Expected return on plan assets	0	0	0	0
Amortization of net loss/(gain)	(43)	0	(86)	0
Amortization of prior service (credit)/cost	(100)	(159)	(300)	(477)
Loss on settlement	0	0	0	0
Net periodic benefit cost/(credit)	(119)	(136)	(294)	(408)
Non-U.S. Plans | Defined Benefit
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]
Service cost	958	725	2,896	3,028
Interest cost	417	405	1,267	1,210
Expected return on plan assets	(214)	(177)	(700)	(534)
Amortization of net loss/(gain)	327	461	935	1,382
Amortization of prior service (credit)/cost	2	3	7	19
Loss on settlement	0	0	0	0
Net periodic benefit cost/(credit)	$ 1,490	$ 1,417	$ 4,405	$ 5,105

Debt - Schedule of Long-term De

Debt - Schedule of Long-term Debt, Finance Lease, and Other Financing Obligations (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Aug. 29, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Less: debt discount, net of premium	$ (3,740)		$ (5,207)
Less: deferred financing costs	(30,952)		(26,682)
Less: current portion	(4,630)		(4,630)
Long-term debt, net	4,208,670		4,214,946
Finance lease and other financing obligations	27,086		28,767
Less: current portion	(1,906)		(2,203)
Finance lease and other financing obligations, less current portion	$ 25,180		26,564
4.875% Senior Notes
Debt Instrument [Line Items]
Debt, stated interest rate	4.875%
5.625% Senior Notes
Debt Instrument [Line Items]
Debt, stated interest rate	5.625%
5.0% Senior Notes
Debt Instrument [Line Items]
Debt, stated interest rate	5%
4.375% Senior Notes
Debt Instrument [Line Items]
Debt, stated interest rate	4.375%
3.75% Senior Notes
Debt Instrument [Line Items]
Debt, stated interest rate	3.75%
4.0% Senior Notes
Debt Instrument [Line Items]
Debt, stated interest rate	4%
5.875% Senior Notes
Debt Instrument [Line Items]
Debt, stated interest rate	5.875%
Secured Debt | Term Loan
Debt Instrument [Line Items]
Gross long-term debt	$ 447,992		$ 451,465
Senior Notes | 4.875% Senior Notes
Debt Instrument [Line Items]
Debt, stated interest rate			4.875%
Gross long-term debt	$ 0		$ 500,000
Senior Notes | 5.625% Senior Notes
Debt Instrument [Line Items]
Debt, stated interest rate	5.625%
Gross long-term debt	$ 400,000		400,000
Senior Notes | 5.0% Senior Notes
Debt Instrument [Line Items]
Debt, stated interest rate	5%
Gross long-term debt	$ 700,000		700,000
Senior Notes | 4.375% Senior Notes
Debt Instrument [Line Items]
Debt, stated interest rate	4.375%
Gross long-term debt	$ 450,000		450,000
Senior Notes | 3.75% Senior Notes
Debt Instrument [Line Items]
Debt, stated interest rate	3.75%
Gross long-term debt	$ 750,000		750,000
Senior Notes | 4.0% Senior Notes
Debt Instrument [Line Items]
Debt, stated interest rate	4%
Gross long-term debt	$ 1,000,000		1,000,000
Senior Notes | 5.875% Senior Notes
Debt Instrument [Line Items]
Debt, stated interest rate	5.875%	5.875%
Gross long-term debt	$ 500,000		$ 0
Less: deferred financing costs		$ (5,900)

Debt - Narrative (Details)

Debt - Narrative (Details) - USD ($)		9 Months Ended
	Aug. 29, 2022	Sep. 30, 2021	Sep. 30, 2022	Jun. 23, 2022	Dec. 31, 2021	Feb. 03, 2021
Debt Instrument [Line Items]
Deferred financing costs			$ 30,952,000		$ 26,682,000
Accrued interest			54,900,000		$ 45,100,000
Eleventh Amendment to Credit Agreement
Debt Instrument [Line Items]
Deferred financing costs			$ 2,600,000
5.875% Senior Notes
Debt Instrument [Line Items]
Debt, stated interest rate			5.875%
5.875% Senior Notes | Debt Instrument, Redemption Period, Prior to September 1, 2025
Debt Instrument [Line Items]
Debt instrument, redemption price, percentage	105.875%
Percentage of principal amount of debt redeemed	40%
Percentage of aggregate principal amount remains outstanding	60%
5.625% Senior Notes
Debt Instrument [Line Items]
Debt, stated interest rate			5.625%
5.0% Senior Notes
Debt Instrument [Line Items]
Debt, stated interest rate			5%
4.0% Senior Notes
Debt Instrument [Line Items]
Debt, stated interest rate			4%
4.375% Senior Notes
Debt Instrument [Line Items]
Debt, stated interest rate			4.375%
3.75% Senior Notes
Debt Instrument [Line Items]
Debt, stated interest rate			3.75%
4.875% Senior Notes
Debt Instrument [Line Items]
Debt, stated interest rate			4.875%
Senior Notes | Occurrence Of Certain Changes In Control
Debt Instrument [Line Items]
Debt instrument, redemption price, percentage	101%
Senior Notes | 5.875% Senior Notes
Debt Instrument [Line Items]
Debt, stated interest rate	5.875%		5.875%
Debt instrument, redemption price, percentage	100%
Debt instrument, face amount	$ 500,000,000
Deferred financing costs	$ 5,900,000
Senior Notes | 5.875% Senior Notes | Changes In Certain Tax Laws Or Treaties
Debt Instrument [Line Items]
Debt instrument, redemption price, percentage	100%
Senior Notes | 5.625% Senior Notes
Debt Instrument [Line Items]
Debt, stated interest rate			5.625%
Senior Notes | 5.0% Senior Notes
Debt Instrument [Line Items]
Debt, stated interest rate			5%
Senior Notes | 4.0% Senior Notes
Debt Instrument [Line Items]
Debt, stated interest rate			4%
Senior Notes | 4.375% Senior Notes
Debt Instrument [Line Items]
Debt, stated interest rate			4.375%
Senior Notes | 3.75% Senior Notes
Debt Instrument [Line Items]
Debt, stated interest rate			3.75%
Senior Notes | 4.875% Senior Notes
Debt Instrument [Line Items]
Debt, stated interest rate					4.875%
Debt instrument, redemption price, percentage	101%
Debt instrument, face amount	$ 500,000,000
Loss on debt redemption	(5,500,000)
Debt redemption, premium paid	$ 5,000,000
Senior Notes | 6.25% Senior Notes
Debt Instrument [Line Items]
Debt, stated interest rate						6.25%
Loss on debt redemption		$ (30,100,000)
Debt redemption, aggregate principal amount		750,000,000
Debt redemption, premium paid		$ 23,400,000
Revolving Credit Facility | Line of Credit | Eleventh Amendment to Credit Agreement
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity				$ 750,000,000
Amount available under revolving credit facility			$ 746,100,000
Letters of credit outstanding, amount			3,900,000
Letter of Credit | Line of Credit | Eleventh Amendment to Credit Agreement
Debt Instrument [Line Items]
Long-term line of credit			$ 0

Debt - Schedule of Debt Instrum

Debt - Schedule of Debt Instrument Redemption (Details) - 5.875% Senior Notes	9 Months Ended
	Sep. 30, 2022
Debt Instrument, Redemption Period, Beginning September 1, 2025
Debt Instrument, Redemption [Line Items]
Debt instrument, redemption price, percentage	102.398%
Debt Instrument, Redemption Period, Beginning September 1, 2026
Debt Instrument, Redemption [Line Items]
Debt instrument, redemption price, percentage	101.469%
Debt Instrument, Redemption Period, Beginning September 1, 2027 and thereafter
Debt Instrument, Redemption [Line Items]
Debt instrument, redemption price, percentage	100%

Shareholders' Equity - Narrativ

Shareholders' Equity - Narrative (Details) - USD ($)		9 Months Ended
	Aug. 24, 2022	Sep. 30, 2022	Sep. 30, 2021	Jan. 20, 2022	Dec. 31, 2021
Equity, Class of Treasury Stock [Line Items]
Dividends declared pre share (in USD per share)	$ 0.11
Dividends paid	$ 17,000,000	$ 34,271,000	$ 0
January 2022 Program
Equity, Class of Treasury Stock [Line Items]
Stock repurchase program, authorized amount				$ 500,000,000
Remaining amount under share repurchase program		$ 272,200,000
July2019 Program
Equity, Class of Treasury Stock [Line Items]
Stock repurchase program, authorized amount				$ 500,000,000
Remaining amount under share repurchase program					$ 254,500,000

Shareholders' Equity - Accumula

Shareholders' Equity - Accumulated Other Comprehensive Loss Roll forward (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning balance	$ 3,023,584	$ 2,913,448	$ 3,094,734	$ 2,705,486
Other comprehensive income before reclassifications, net of tax			48,437
Reclassifications from accumulated other comprehensive income/(loss), net of tax			(24,690)
Other comprehensive income	10,906	3,569	23,747	22,629
Ending balance	3,069,318	3,009,623	3,069,318	3,009,623
Cash Flow Hedges
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning balance			16,831
Other comprehensive income before reclassifications, net of tax			48,437
Reclassifications from accumulated other comprehensive income/(loss), net of tax			(26,075)
Other comprehensive income			22,362
Ending balance	39,193		39,193
Defined Benefit and Retiree Healthcare Plans
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning balance			(36,391)
Other comprehensive income before reclassifications, net of tax			0
Reclassifications from accumulated other comprehensive income/(loss), net of tax			1,385
Other comprehensive income			1,385
Ending balance	(35,006)		(35,006)
Accumulated Other Comprehensive Income/(Loss)
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning balance	(6,719)	(30,475)	(19,560)	(49,535)
Other comprehensive income	10,906	3,569	23,747	22,629
Ending balance	$ 4,187	$ (26,906)	$ 4,187	$ (26,906)

Shareholders' Equity - Accumu_2

Shareholders' Equity - Accumulated Other Comprehensive Loss Reclassifications (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net revenue	$ 1,018,268	$ 951,021	$ 3,014,586	$ 2,886,209
Cost of revenue	(694,535)	(628,922)	(2,038,218)	(1,922,556)
Provision for income taxes	(46,421)	(21,840)	(74,029)	(49,759)
Other, net	(21,371)	(9,403)	(111,067)	(47,788)
Net income	140,253	84,959	197,535	251,608
(Gain)/Loss Reclassified from Accumulated Other Comprehensive Loss | Derivative instruments designated and qualifying as cash flow hedges:
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Income before taxes	(16,169)	(1,581)	(35,141)	3,492
Provision for income taxes	4,172	395	9,066	(873)
Net income	(11,997)	(1,186)	(26,075)	2,619
(Gain)/Loss Reclassified from Accumulated Other Comprehensive Loss | Derivative instruments designated and qualifying as cash flow hedges: | Foreign currency forward contracts
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net revenue	(14,909)	1,976	(28,649)	9,816
Cost of revenue	(1,260)	(3,557)	(6,492)	(6,324)
(Gain)/Loss Reclassified from Accumulated Other Comprehensive Loss | Defined benefit and retiree healthcare plans
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Provision for income taxes	(148)	(269)	(470)	(1,285)
Other, net	725	863	1,855	5,263
Net income	$ 577	$ 594	$ 1,385	$ 3,978

Fair Value Measures - Schedule

Fair Value Measures - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - Level 2 - Recurring - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets	$ 66,111	$ 28,091
Liabilities	27,384	7,565
Foreign currency forward contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets	65,808	25,112
Liabilities	13,087	3,073
Commodity forward contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets	303	2,979
Liabilities	$ 14,297	$ 4,492

Fair Value Measures - Narrative

Fair Value Measures - Narrative (Details) $ / shares in Units, $ in Thousands	Oct. 06, 2022 $ / shares shares	Feb. 08, 2022 USD ($) $ / shares shares	Sep. 30, 2022 USD ($) $ / shares shares	Jun. 30, 2022 USD ($) $ / shares shares	Mar. 31, 2022 shares	Dec. 31, 2021 USD ($)
Schedule of Equity Method Investments [Line Items]
Equity securities without readily determinable fair value			$ 15,000			$ 65,000
Quanergy Systems, Inc.
Schedule of Equity Method Investments [Line Items]
Share price (in dollars per share) | $ / shares		$ 7.05
Quanergy Systems, Inc. | Subsequent Event
Schedule of Equity Method Investments [Line Items]
Stock split ratio	0.05
Quanergy Systems, Inc.
Schedule of Equity Method Investments [Line Items]
Equity securities without readily determinable fair value		$ 75,100	$ 1,708	$ 3,383		50,000
Equity securities without readily determinable fair value (in shares) | shares		8,250,000	8,250,000	8,250,000
Share price (in dollars per share) | $ / shares		$ 7.05	$ 0.21	$ 0.41
Support agreement term		4 years
Support agreement, consideration		$ 17,600
Quanergy Systems, Inc. | Subsequent Event
Schedule of Equity Method Investments [Line Items]
Equity securities without readily determinable fair value (in shares) | shares	400,000
Share price (in dollars per share) | $ / shares	$ 4.14
Quanergy Systems, Inc. | Warrants
Schedule of Equity Method Investments [Line Items]
Equity securities without readily determinable fair value		$ 17,600	$ 0	$ 0		0
Equity securities without readily determinable fair value (in shares) | shares		2,500,000	7,500,000		5,000,000
Number of shares called by each warrant (in shares) | shares		1
Exercise price of warrants shares (in dollars per share) | $ / shares		$ 0.01
Quanergy Systems, Inc. | Series B Investment
Schedule of Equity Method Investments [Line Items]
Equity securities without readily determinable fair value		$ 0	$ 0	0		50,000
Share price (in dollars per share) | $ / shares		$ 10
Quanergy Systems, Inc. | Ordinary Shares
Schedule of Equity Method Investments [Line Items]
Equity securities without readily determinable fair value		$ 50,000	1,553	3,075		0
Equity securities without readily determinable fair value (in shares) | shares		5,000,000
Quanergy Systems, Inc. | Unregistered Common Shares
Schedule of Equity Method Investments [Line Items]
Equity securities without readily determinable fair value		$ 7,500	$ 155	$ 308		$ 0
Equity securities without readily determinable fair value (in shares) | shares		750,000
Quanergy Systems, Inc. | Common Stock, Including Unregistered
Schedule of Equity Method Investments [Line Items]
Equity securities without readily determinable fair value		$ 57,500
Equity securities without readily determinable fair value (in shares) | shares		5,750,000

Fair Value Measures - Schedul_2

Fair Value Measures - Schedule of Investment in Quanergy (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2022	Sep. 30, 2021	Jun. 30, 2022	Mar. 31, 2022	Feb. 08, 2022	Dec. 31, 2021
Schedule of Equity Method Investments [Line Items]
Total equity investment in Quanergy	$ 15,000	$ 15,000					$ 65,000
Mark-to-market loss		$ 75,135	$ 0
Quanergy Systems, Inc.
Schedule of Equity Method Investments [Line Items]
Share price (in dollars per share)	$ 0.21	$ 0.21		$ 0.41		$ 7.05
Total shares of Quanergy held, including Warrants (in shares)	8,250,000	8,250,000		8,250,000		8,250,000
Total equity investment in Quanergy	$ 1,708	$ 1,708		$ 3,383		$ 75,100	50,000
Mark-to-market loss	1,675	73,392
Quanergy Systems, Inc. | Series B Investment
Schedule of Equity Method Investments [Line Items]
Share price (in dollars per share)						$ 10
Total equity investment in Quanergy	0	0		0		$ 0	50,000
Quanergy Systems, Inc. | Common shares
Schedule of Equity Method Investments [Line Items]
Total shares of Quanergy held, including Warrants (in shares)						5,000,000
Total equity investment in Quanergy	1,553	1,553		3,075		$ 50,000	0
Quanergy Systems, Inc. | PIPE investment
Schedule of Equity Method Investments [Line Items]
Total shares of Quanergy held, including Warrants (in shares)						750,000
Total equity investment in Quanergy	$ 155	$ 155		308		$ 7,500	0
Quanergy Systems, Inc. | Warrants
Schedule of Equity Method Investments [Line Items]
Total shares of Quanergy held, including Warrants (in shares)	7,500,000	7,500,000			5,000,000	2,500,000
Total equity investment in Quanergy	$ 0	$ 0		$ 0		$ 17,600	$ 0

Fair Value Measures - Financial

Fair Value Measures - Financial Instruments Not Recorded at Fair Value (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
4.875% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt, stated interest rate	4.875%
5.625% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt, stated interest rate	5.625%
5.0% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt, stated interest rate	5%
4.375% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt, stated interest rate	4.375%
3.75% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt, stated interest rate	3.75%
4.0% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt, stated interest rate	4%
5.875% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt, stated interest rate	5.875%
Level 2 | Carrying Value | Term Loan
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	$ 447,992	$ 451,465
Level 2 | Carrying Value | 4.875% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	0	500,000
Level 2 | Carrying Value | 5.625% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	400,000	400,000
Level 2 | Carrying Value | 5.0% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	700,000	700,000
Level 2 | Carrying Value | 4.375% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	450,000	450,000
Level 2 | Carrying Value | 3.75% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	750,000	750,000
Level 2 | Carrying Value | 4.0% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	1,000,000	1,000,000
Level 2 | Carrying Value | 5.875% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	500,000	0
Level 2 | Term Loan
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	444,632	450,901
Level 2 | 4.875% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	0	526,250
Level 2 | 5.625% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	394,000	438,000
Level 2 | 5.0% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	661,500	759,500
Level 2 | 4.375% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	373,500	479,250
Level 2 | 3.75% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	579,375	747,188
Level 2 | 4.0% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	820,000	1,022,500
Level 2 | 5.875% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	$ 463,750	$ 0

Fair Value Measures - Equity In

Fair Value Measures - Equity Instruments without Readily Determinable Fair Values (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Jun. 30, 2022	Feb. 08, 2022	Dec. 31, 2021
Schedule of Equity Method Investments [Line Items]
Equity securities without readily determinable fair value	$ 15,000			$ 65,000
Quanergy Systems, Inc.
Schedule of Equity Method Investments [Line Items]
Equity securities without readily determinable fair value	1,708	$ 3,383	$ 75,100	50,000
Other
Schedule of Equity Method Investments [Line Items]
Equity securities without readily determinable fair value	$ 15,000			$ 15,000

Derivative Instruments and He_3

Derivative Instruments and Hedging Activities - Narrative (Details)	Sep. 30, 2022 USD ($)
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Foreign currency cash flow gain to be reclassified during next 12 months	$ 46,400,000
Termination value of outstanding derivatives in a liability position	27,800,000
Collateral already posted, aggregate fair value	$ 0

Derivative Instruments and He_4

Derivative Instruments and Hedging Activities - Schedule of Derivative Instruments (Details) - 9 months ended Sep. 30, 2022 € in Millions, ₩ in Millions, ¥ in Millions, £ in Millions, RM in Millions, $ in Millions	EUR (€) lb ozt $ / $ € / $ £ / $ $ / RM $ / ¥ $ / ₩	CNY (¥) $ / $ € / $ £ / $ $ / RM $ / ¥ $ / ₩	KRW (₩) $ / $ € / $ £ / $ $ / RM $ / ¥ $ / ₩	MYR (RM) $ / $ € / $ £ / $ $ / RM $ / ¥ $ / ₩	MXN ($) $ / $ € / $ £ / $ $ / RM $ / ¥ $ / ₩	GBP (£) $ / $ € / $ £ / $ $ / RM $ / ¥ $ / ₩
Foreign currency forward contracts | Not designated | Euro ("EUR") to USD
Hedges of Foreign Currency Risk
Notional | €	€ 32
Weighted-Average Strike Rate | € / $	0.96	0.96	0.96	0.96	0.96	0.96
Foreign currency forward contracts | Not designated | USD to Chinese Renminbi ("CNY")
Hedges of Foreign Currency Risk
Notional | ¥		¥ 471
Weighted-Average Strike Rate | $ / ¥	7.14	7.14	7.14	7.14	7.14	7.14
Foreign currency forward contracts | Not designated | USD to Malaysian Ringgit ("MYR")
Hedges of Foreign Currency Risk
Notional | RM				RM 23
Weighted-Average Strike Rate | $ / RM	4.63	4.63	4.63	4.63	4.63	4.63
Foreign currency forward contracts | Not designated | USD to Mexican Peso ("MXN")
Hedges of Foreign Currency Risk
Notional | $					$ 266
Weighted-Average Strike Rate | $ / $	20.43	20.43	20.43	20.43	20.43	20.43
Foreign currency forward contracts | Not designated | British Pound Sterling ("GBP") to USD
Hedges of Foreign Currency Risk
Notional | £						£ 10
Weighted-Average Strike Rate | £ / $	1.06	1.06	1.06	1.06	1.06	1.06
Foreign currency forward contracts | Cash flow hedge | Euro ("EUR") to USD
Hedges of Foreign Currency Risk
Notional | €	€ 364.7
Weighted-Average Strike Rate | € / $	1.13	1.13	1.13	1.13	1.13	1.13
Foreign currency forward contracts | Cash flow hedge | USD to Chinese Renminbi ("CNY")
Hedges of Foreign Currency Risk
Notional | ¥		¥ 378.1
Weighted-Average Strike Rate | $ / ¥	6.47	6.47	6.47	6.47	6.47	6.47
Foreign currency forward contracts | Cash flow hedge | USD to Korean Won ("KRW")
Hedges of Foreign Currency Risk
Notional | ₩			₩ 21,673.3
Weighted-Average Strike Rate | $ / ₩	1,208	1,208	1,208	1,208	1,208	1,208
Foreign currency forward contracts | Cash flow hedge | USD to Mexican Peso ("MXN")
Hedges of Foreign Currency Risk
Notional | $					$ 3,525.3
Weighted-Average Strike Rate | $ / $	22.20	22.20	22.20	22.20	22.20	22.20
Foreign currency forward contracts | Cash flow hedge | British Pound Sterling ("GBP") to USD
Hedges of Foreign Currency Risk
Notional | £						£ 60.2
Weighted-Average Strike Rate | £ / $	1.29	1.29	1.29	1.29	1.29	1.29
Silver | Not designated
Hedges of Foreign Currency Risk
Weighted-Average Strike Rate	23.89	23.89	23.89	23.89	23.89	23.89
Hedges of Commodity Risk
Notional	983,717
Gold | Not designated
Hedges of Foreign Currency Risk
Weighted-Average Strike Rate	1,861.62	1,861.62	1,861.62	1,861.62	1,861.62	1,861.62
Hedges of Commodity Risk
Notional	7,757
Nickel | Not designated
Hedges of Foreign Currency Risk
Weighted-Average Strike Rate	10.27	10.27	10.27	10.27	10.27	10.27
Hedges of Commodity Risk
Notional | lb	255,206
Aluminum | Not designated
Hedges of Foreign Currency Risk
Weighted-Average Strike Rate	1.23	1.23	1.23	1.23	1.23	1.23
Hedges of Commodity Risk
Notional | lb	4,225,448
Copper | Not designated
Hedges of Foreign Currency Risk
Weighted-Average Strike Rate	4.23	4.23	4.23	4.23	4.23	4.23
Hedges of Commodity Risk
Notional | lb	8,124,126
Platinum | Not designated
Hedges of Foreign Currency Risk
Weighted-Average Strike Rate	1,000.8	1,000.8	1,000.8	1,000.8	1,000.8	1,000.8
Hedges of Commodity Risk
Notional	11,503
Palladium | Not designated
Hedges of Foreign Currency Risk
Weighted-Average Strike Rate	2,291.99	2,291.99	2,291.99	2,291.99	2,291.99	2,291.99
Hedges of Commodity Risk
Notional	1,340

Derivative Instruments and He_5

Derivative Instruments and Hedging Activities - Fair Value (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Cash flow hedge
Derivatives, Fair Value [Line Items]
Asset Derivatives	$ 65,708	$ 24,953
Liability Derivatives	12,281	2,885
Not designated
Derivatives, Fair Value [Line Items]
Asset Derivatives	403	3,138
Liability Derivatives	15,103	4,680
Foreign currency forward contracts | Cash flow hedge | Prepaid expenses and other current assets
Derivatives, Fair Value [Line Items]
Asset Derivatives	55,457	20,562
Foreign currency forward contracts | Cash flow hedge | Other assets
Derivatives, Fair Value [Line Items]
Asset Derivatives	10,251	4,391
Foreign currency forward contracts | Cash flow hedge | Accrued expenses and other current liabilities
Derivatives, Fair Value [Line Items]
Liability Derivatives	9,630	1,981
Foreign currency forward contracts | Cash flow hedge | Other long-term liabilities
Derivatives, Fair Value [Line Items]
Liability Derivatives	2,651	904
Foreign currency forward contracts | Not designated | Prepaid expenses and other current assets
Derivatives, Fair Value [Line Items]
Asset Derivatives	100	159
Foreign currency forward contracts | Not designated | Accrued expenses and other current liabilities
Derivatives, Fair Value [Line Items]
Liability Derivatives	806	188
Commodity forward contracts | Not designated | Prepaid expenses and other current assets
Derivatives, Fair Value [Line Items]
Asset Derivatives	218	2,583
Commodity forward contracts | Not designated | Other assets
Derivatives, Fair Value [Line Items]
Asset Derivatives	85	396
Commodity forward contracts | Not designated | Accrued expenses and other current liabilities
Derivatives, Fair Value [Line Items]
Liability Derivatives	11,338	3,422
Commodity forward contracts | Not designated | Other long-term liabilities
Derivatives, Fair Value [Line Items]
Liability Derivatives	$ 2,959	$ 1,070

Derivative Instruments and He_6

Derivative Instruments and Hedging Activities - Income Statement Disclosures (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Foreign currency forward contracts | Not designated
Derivative Instruments, Gain (Loss) [Line Items]
Amount of (Loss)/Gain Recognized in Net Income	$ 6,178	$ (2,414)	$ 8,100	$ (4,791)
Foreign currency forward contracts | Net revenue | Cash flow hedge
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Deferred Gain/(Loss) Recognized in Other Comprehensive Income	35,324	9,379	69,102	21,825
Amount of Net Gain/(Loss) Reclassified from Accumulated Other Comprehensive Income/(Loss) into Net Income	14,909	(1,976)	28,649	(9,816)
Foreign currency forward contracts | Cost of revenue | Cash flow hedge
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Deferred Gain/(Loss) Recognized in Other Comprehensive Income	(5,204)	(3,832)	(3,824)	(449)
Amount of Net Gain/(Loss) Reclassified from Accumulated Other Comprehensive Income/(Loss) into Net Income	1,260	3,557	6,492	6,324
Commodity forward contracts | Not designated
Derivative Instruments, Gain (Loss) [Line Items]
Amount of (Loss)/Gain Recognized in Net Income	$ (5,773)	$ (6,495)	$ (14,603)	$ (6,462)

Acquisitions and Divestitures -

Acquisitions and Divestitures - Acquisitions (Details) - USD ($) $ in Thousands			3 Months Ended	9 Months Ended
	Feb. 11, 2022	Nov. 19, 2021	Sep. 30, 2022	Sep. 30, 2022	Sep. 30, 2021	Jul. 12, 2022	Dec. 31, 2021
Business Acquisition [Line Items]
Acquisition-related compensation payments				$ 23,500	$ 7,000
Goodwill			$ 3,847,450	3,847,450			$ 3,502,063
Spear Power Systems
Business Acquisition [Line Items]
Aggregate purchase price		$ 113,700
Business acquisition contingent consideration (up to)		30,000
Business acquisition contingent consideration		8,600	0	0
Business combination gain recognized				8,600
SmartWitness
Business Acquisition [Line Items]
Aggregate purchase price		206,400
Cash paid to acquire business		204,200
Acquisition costs related to employee retention		$ 8,600
Elastic M2M Inc
Business Acquisition [Line Items]
Aggregate purchase price	$ 51,600
Acquisition-related incentive compensation	30,000
Compensation earned			$ 2,000	20,400
Acquisition-related compensation payments				$ 15,000
Goodwill	$ 24,708
Dynapower
Business Acquisition [Line Items]
Goodwill						$ 357,380

Acquisitions and Divestitures_2

Acquisitions and Divestitures - Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Jul. 12, 2022	Feb. 11, 2022	Dec. 31, 2021
Business Acquisition [Line Items]
Goodwill	$ 3,847,450			$ 3,502,063
Elastic M2M Inc
Business Acquisition [Line Items]
Net working capital, excluding cash			$ 35
Goodwill			24,708
Other intangible assets			33,500
Deferred income tax liabilities			(8,222)
Fair value of net assets acquired, excluding cash and cash equivalents			50,021
Cash and cash equivalents			1,597
Fair value of net assets acquired			$ 51,618
Dynapower
Business Acquisition [Line Items]
Net working capital, excluding cash		$ 25,333
Goodwill		357,380
Other intangible assets		229,100
Other long-term liabilities		(38,483)
Fair value of net assets acquired, excluding cash and cash equivalents		573,330
Cash and cash equivalents		4,410
Fair value of net assets acquired		$ 577,740

Acquisitions and Divestitures_3

Acquisitions and Divestitures - Schedule of Finite-Lived Intangible Assets Acquired and Weighted Average Useful Lives (Details) - USD ($) $ in Thousands	Jul. 12, 2022	Feb. 11, 2022
Elastic M2M Inc
Acquired Finite-Lived Intangible Assets [Line Items]
Acquisition Date Fair Value		$ 33,500
Weighted-Average Lives (years)		12 years
Elastic M2M Inc | Customer relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Acquisition Date Fair Value		$ 23,300
Weighted-Average Lives (years)		13 years
Elastic M2M Inc | Completed technologies
Acquired Finite-Lived Intangible Assets [Line Items]
Acquisition Date Fair Value		$ 10,200
Weighted-Average Lives (years)		10 years
Dynapower
Acquired Finite-Lived Intangible Assets [Line Items]
Acquisition Date Fair Value	$ 229,100
Weighted-Average Lives (years)	11 years
Dynapower | Customer relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Acquisition Date Fair Value	$ 145,600
Weighted-Average Lives (years)	11 years
Dynapower | Completed technologies
Acquired Finite-Lived Intangible Assets [Line Items]
Acquisition Date Fair Value	$ 75,700
Weighted-Average Lives (years)	10 years
Dynapower | Tradenames
Acquired Finite-Lived Intangible Assets [Line Items]
Acquisition Date Fair Value	$ 7,800
Weighted-Average Lives (years)	10 years

Acquisitions and Divestitures_4

Acquisitions and Divestitures - Divestitures (Details) - Disposal Group, Disposed of by Sale, Not Discontinued Operations - Qinex Business - USD ($) $ in Millions		1 Months Ended	3 Months Ended	9 Months Ended
	May 27, 2022	Aug. 31, 2022	Sep. 30, 2022	Sep. 30, 2022	Jul. 31, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Consideration on sale of business	$ 219				$ 198.8
Contract manufacturing agreement, extension period	3 months
Disposal group, assets held for sale					70
Disposal group, goodwill					45
Disposal group, liabilities					$ 2
Proceed from transition services agreement		$ 5
Pre tax gain on sale of business			$ 135.1
Transaction costs			$ 13.5	$ 15.6
Minimum
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Contract manufacturing agreement, term	6 months
Maximum
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Contract manufacturing agreement, term	9 months

Segment Reporting - Schedules o

Segment Reporting - Schedules of Segment Reporting (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($) segment	Sep. 30, 2021 USD ($)
Segment Reporting Information [Line Items]
Number of reporting segments | segment			2
Reconciliation from Segment Totals to Consolidated [Abstract]
Net revenue	$ 1,018,268	$ 951,021	$ 3,014,586	$ 2,886,209
Operating income	252,901	161,339	517,774	483,548
Amortization of intangible assets	(40,313)	(34,571)	(114,485)	(101,492)
Interest expense, net	(44,856)	(45,137)	(135,143)	(134,393)
Other, net	(21,371)	(9,403)	(111,067)	(47,788)
Income before taxes	186,674	106,799	$ 271,564	301,367
Performance Sensing
Segment Reporting Information [Line Items]
Number of operating segments | segment			2
Reconciliation from Segment Totals to Consolidated [Abstract]
Net revenue	754,527	706,466	$ 2,219,106	2,162,830
Sensing Solutions
Reconciliation from Segment Totals to Consolidated [Abstract]
Net revenue	263,741	244,555	795,480	723,379
Operating segments
Reconciliation from Segment Totals to Consolidated [Abstract]
Net revenue	1,018,268	951,021	3,014,586	2,886,209
Operating income	262,182	269,004	780,342	810,355
Operating segments | Performance Sensing
Reconciliation from Segment Totals to Consolidated [Abstract]
Net revenue	754,527	706,466	2,219,106	2,162,830
Operating income	188,560	193,742	554,717	591,650
Operating segments | Sensing Solutions
Reconciliation from Segment Totals to Consolidated [Abstract]
Net revenue	263,741	244,555	795,480	723,379
Operating income	73,622	75,262	225,625	218,705
Corporate and other
Reconciliation from Segment Totals to Consolidated [Abstract]
Operating income	(76,409)	(72,749)	(228,894)	(215,359)
Segment reconciling items
Reconciliation from Segment Totals to Consolidated [Abstract]
Amortization of intangible assets	(40,313)	(34,571)	(114,485)	(101,492)
Restructuring and other charges, net	$ 107,441	$ (345)	$ 80,811	$ (9,956)